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 A novel Type IV secretion system (T4SS) was identified in Legionella pneumophila isolates from 
the Edinburgh Legionnaires’ disease outbreak in 2012. A phylogenetic reconstruction of the isolates 
shows four distinct clades, two of which share a region thought to encode the novel T4SS. In a Galleria 
mellonella infection model, strains with this T4SS caused more rapid killing than those without it. 
Furthermore, patients infected with isolates containing the novel T4SS required more clinical care 
intervention. This project aims to dissect the role of the novel T4SS in intracellular survival. 
Bioinformatic analysis showed that the T4SS is closely related to the Legionella genomic island-
associated T4SS (LGI-T4SS) of L. longbeachae. Other bioinformatic tools were used to identify 
neighbouring genes predicted to encode T4SS-secreted effector proteins. The expression of these 
genes was then detected during broth culture and intracellular growth using RT-PCR. A range of 
techniques were employed in order to compare the intracellular survival, replication and virulence of 
representative isolates from each of the four clades. Macrophage-like cells were infected in a 
gentamicin protection assay to compare intracellular replication. DNA extracted from the infected 
cells at four time points was quantified by qPCR to measure replication of the bacteria over time. In 
addition, the level of host cell death and autophagy was compared in macrophage-like cells infected 
with representative isolates from each clade. The results indicate that the region encoding the novel 
T4SS originated in L. longbeachae and encodes at least one putative T4SS effector protein. Although 
no difference was observed in host cell death and autophagy during infection with representative 





 Type IV secretion systems (T4SSs) are protein structures used by bacterial cells to transfer 
genes and proteins into host cells. A novel T4SS was identified in Legionella pneumophila isolates from 
the Edinburgh Legionnaires’ disease outbreak in 2012. It was previously shown that isolates with this 
T4SS cause more rapid killing than those without it. Furthermore, patients infected with isolates 
containing the novel T4SS required more clinical care intervention. This project aims to dissect the 
role of the novel T4SS in the intracellular survival of L. pneumophila. Bioinformatic analysis showed 
that the T4SS is closely related to a T4SS found in another species, Legionella longbeachae. A range of 
techniques were employed to compare the survival of isolates with and without the novel T4SS. 
Although no difference was observed in host cell death during infection with the different isolates, 
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Chapter 1: Introduction 
Legionnaires’ disease 
 The first known outbreak of Legionnaires’ disease occurred at an American Legion convention 
in Philadelphia in 1976 (Fraser et al., 1977). Of 182 recorded cases, 29 were fatal and 147 required 
hospital care. The causative agent, L. pneumophila was isolated the following year from samples taken 
from the patients’ lungs (McDade et al., 1977). Although more than 50 species of Legionella have now 
been identified, L. pneumophila is associated with more than 90% of Legionnaires’ disease cases 
worldwide (Jarraud et al., 2013). 
 Human infection by L. pneumophila occurs through the inhalation of contaminated aerosols 
from artificial aquatic environments such as air conditioning systems, cooling towers and hot tubs 
(Bartram, 2007). As water temperatures of 25 to 42°C are optimal for Legionella growth, these water 
systems can promote the rapid amplification of Legionella to high concentrations, thereby increasing 
the risk of infection (Kozak et al., 2013).  
 Once inside the human lung, L. pneumophila can cause acute alveolitis and bronchiolitis 
(Swanson and Hammer, 2000). However, human monocytes activated by the inflammatory cytokine 
interferon-γ can inhibit intracellular multiplication of the bacterium by overriding the ability of the 
bacteria to evade the lysosomal degradation pathway (Santic et al., 2005). Therefore the majority of 
people exposed to L. pneumophila either do not become ill or suffer only a mild self-limiting infection 
(Newton et al., 2010).  
 The clinical symptoms of Legionnaires’ disease include fever, non-productive cough, 
headache, breathing difficulties and diarrhoea (TSAI et al., 1979). As these symptoms are 
indistinguishable from those of other forms of pneumonia, diagnostic tests must be carried out in 
order to establish the causative agent (Bartram, 2007). Most cases are now identified by urinary 
antigen tests, although cultures of either sputum or bronchoalveolar lavage may also be used 
(European Centre for Disease Prevention and Control, 2015).  
 The majority of individuals who develop Legionnaires’ disease are elderly or 
immunocompromised (Berrington and Hawn, 2013). For example, 81% of European cases in 2013 
occurred in people over 50 years of age (European Centre for Disease Prevention and Control, 2015). 
Further risk factors for the disease include cigarette smoking, immunosuppressant treatment and 
chronic lung disease (Swanson and Hammer, 2000). In Europe, the overall case-fatality rate is 
approximately 12%, although this varies considerably according to the severity of disease, the quality 
and time of treatment and other risk factors (Bartram, 2007).  
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 Between 1994 and 2008, almost 54,000 cases were reported across 30 European countries 
(Joseph and Ricketts, 2010). The largest outbreak to date originated from the cooling towers of a city 
hospital in Murcia, Spain in 2001, where 449 cases were confirmed (García-Fulgueiras et al., 2003).  
 
Models of Legionnaires’ disease 
 Early evidence for the effective treatment of Legionnaires’ disease was provided using a 
guinea pig model of infection (Edelstein et al., 1984). Intratracheal inoculation resulted in lung 
histopathology and bacteriology that was almost identical to that caused by Legionnaires’ disease in 
humans. In this model, fatality rates were significantly reduced by treatment with either erythromycin, 
rifampicin, doxycycline or cotrimoxazole. More recently, the two antimicrobials fluoroquinolone and 
azithromycin were recommended for the treatment of human infections by the Infectious Diseases 
Society of America in 2007 (Mandell et al., 2007). 
 A guinea pig model of infection was also used to test the efficacy of immunisation with the 
major secretory protein (MSP) of L. pneumophila (Blander and Horwitz, 1991b). This protein is a Zn2+ 
metalloprotease encoded by the mspA gene (Szeto and Shuman, 1990). Although the MSP is the most 
abundant protein in culture supernatants of the bacteria, it is not required for intracellular growth or 
destruction of human macrophages. Nevertheless, immunisation with the MSP was shown to induce 
significant protective immunity against aerosolised L. pneumophila in the guinea pig model (Blander 
and Horwitz, 1991b). Additionally, immunisation by aerosolised L. pneumophila membranes was also 
shown to induce protective immunity in the guinea pig model (Blander and Horwitz, 1991a). The 
guinea pig infection model has also been used to study host immune defences and to measure the 
relative virulence of different Legionella strains (Edelstein, 2013).  
 More recently, a DNA vaccine has been shown to protect the A/J mouse against L. 
pneumophila infection (Xu et al., 2012). This vaccine encodes a 29 kDa outer membrane protein and 
the Type IV pili protein (PilE) of L. pneumophila. 
 
Legionella pneumophila 
Legionella pneumophila is an aerobic, Gram-negative coccobacillus which multiplies inside 
freshwater and soil amoebae (Newton et al., 2010, Chien et al., 2004). The bacterium evades 
lysosomal degradation inside these cells through the formation of a specialised phagosomal 
compartment, known as the Legionella-containing vacuole (LCV) (Allombert et al., 2013). This 
9 
 
mechanism also enables L. pneumophila to survive within alveolar macrophages, causing Legionnaires’ 
disease (Brüggemann et al., 2006). Outbreaks result from the inhalation of contaminated aerosols 
from various water sources, making L. pneumophila an opportunistic and accidental pathogen of 
humans (Bartram, 2007). 
L. pneumophila replicates intracellularly in over 13 species of amoebae, including several 
species of Acanthamoeba, Hartmannella and Naegleria (Fields, 1996). During its life cycle in both 
amoebae and macrophages, L. pneumophila alternates between several distinct phenotypic forms 
(Garduno et al., 2002). The replicative form (RF) is non-motile, thin walled and acid tolerant, whereas 
the mature intracellular form (MIF) is motile and resilient for survival in the extracellular environment 
(Dalebroux et al., 2010). Furthermore, MIFs can resist detergent-mediated lysis and high pH conditions 
(Garduno et al., 2002). The viable but non-culturable (VBNC) form is a dormant phenotype which 
enables the bacteria to survive in unfavourable environmental conditions (Al‐Bana et al., 2014). 
L. pneumophila is taken up into host cells by phagocytosis (Newton et al., 2010). Once inside 
the host cell phagosome, the bacterium initiates formation of the LCV (Figure 1) (Allombert et al., 
2013). This compartment resists fusion with lysosomes, protects the bacterium from immune 
detection and provides nutrients for intracellular replication (Xu and Luo, 2013, Horwitz, 1983b). 
Within the LCV, the bacteria differentiate into the RF (Swanson and Hammer, 2000). As the nutrients 
inside the LCV become depleted over time, the bacteria differentiate into the MIF, which is able to 
infect a new host cell.  
In order to form the LCV, L. pneumophila recruits host cell mitochondria and endoplasmic 
reticulum (ER) vesicles to the surface of the phagosome within 5 minutes of internalisation (Tilney et 
al., 2001). Next, the ER-derived membranes fuse with the LCV and the resulting LCV membrane 
gradually accumulates other materials from the host cell, including ribosomes, ubiquitinated proteins 
and vacuolar ATPases (Xu and Luo, 2013, Hubber and Roy, 2010). As a result of these modifications, 
the LCV membrane resembles that of the rough ER by approximately 4 hours post-infection (Horwitz, 
1983a).  
The outer surface of the LCV membrane is characterised by the accumulation of the 
membrane lipid phosphatidylinositol 4-phosphate (PI(4)P) and secreted bacterial proteins (Allombert 
et al., 2013). As PI(4)P is a marker of the Golgi membrane, this feature favours the fusion of additional 
ER vesicles with the LCV membrane. Furthermore, phosphatidyl phosphoinositides act as anchors for 





Figure 1 LCV biogenesis by L. pneumophila (Allombert et al., 2013). Once inside the host cell, avirulent L. pneumophila are 
cleared via the endosomal pathway and fusion with lysosomes. In contrast, virulent L. pneumophila form the LCV by 
recruitment of mitochondria, ER-derived smooth vesicles and ribosomes. Inside the LCV, L. pneumophila escape lysosomal 





Host cell response  
The autophagy pathway is activated as an immediate response to Legionella during infection 
of macrophages (Amer and Swanson, 2005). During autophagy, intracellular bacteria are packaged 
into double membrane-bound phagosomes, which undergo maturation before fusing with lysosomes 
(Xie and Klionsky, 2007). This fusion results in degradation of the bacteria by lysosomal hydrolases.  
During autophagy, a protein called Atg8 undergoes a modification at its C-terminus, and is 
then covalently attached to the lipid phosphatidylethanolamine on the phagosome membrane 
(Ichimura et al., 2000). This process has been shown to be essential to the autophagy pathway. 
However, some L. pneumophila strains secrete a cysteine protease called RavZ which inhibits the 
autophagy pathway by removing Atg8 from the membrane and removing the C-terminus modification 
necessary for lipid conjugation (Choy et al., 2012). 
Most inbred mouse strains are resistant to L. pneumophila infection (Hori and Zamboni, 2013). 
However, a murine model of Legionnaires’ disease has been developed with mice of the A/J strain, 
which do support the growth of L. pneumophila (Brieland et al., 1994). This variation in resistance is 
caused by different alleles encoding a Nucleotide-binding Oligomerisation Domain Leucine-Rich 
Repeat (NOD-LRR) protein called Neuronal Apoptosis Inhibitory Protein 5 (NAIP5) (also called Birc1e), 
a component of the NAIP5-NLRC4 inflammasome (Diez et al., 2003).  
In resistant macrophages, a 35-amino acid region of the L. pneumophila protein flagellin 
triggers activation of the inflammasome and the consequent proteolytic activation of caspase-1 
(Lightfield et al., 2008). Together with the NOD-like receptor (NLR) protein NLRC4 (also called Ipaf), 
NAIP5 is required for this flagellin-induced caspase-1 activation (Amer et al., 2006). NAIP5 and 
caspase-1 both contribute to the activation of caspase-7, which promotes fusion of the LCV with the 
lysosome (Akhter et al., 2009).  
Active caspase-1 also induces a pro-inflammatory form of cell death called pyroptosis 
(Bergsbaken et al., 2009). During pyroptosis, pores are formed in the plasma membrane, causing 
osmotic lysis and release of lactate dehydrogenase (Silveira and Zamboni, 2010). In addition, the pro-
inflammatory cytokines IL-1β and IL-18 are activated and released from the cell (Bergsbaken et al., 
2009).  
 In contrast, in human macrophage-like U937 cells, the transcriptional regulator NF-κB induces 
the up-regulation of anti-apoptotic genes in response to L. pneumophila infection (Losick and Isberg, 
2006). The resulting anti-apoptotic pathway promotes survival of the host cell. Furthermore, the 
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secreted effector protein SidF specifically interacts with and inhibits two apoptotic proteins, BNIP3 
and Bcl-rambo (Banga et al., 2007). 
 
Genetics 
 Approximately 66% of the L. pneumophila genome is differentially expressed during 
intracellular growth compared to growth in laboratory media (Faucher et al., 2011). The number of 
genes expressed gradually increases during the first 18 hours of infection. Genes induced 
intracellularly include those involved in amino acid biosynthesis, amino acid uptake, iron uptake and 
glycerol catabolism.  
 Although all of the sequenced L. pneumophila strains contain a single circular chromosome 
between 3.3Mb and 3.5Mb in length, the gene content specific to each of four strains (Paris, Corby, 
Philadelphia and Lens) was found to be as high as 11% (Gomez-Valero et al., 2009). This high level of 
plasticity between the genomes of different strains has been linked to frequent recombination events 
and horizontal gene transfer (Gomez-Valero et al., 2011). For example, the horizontal transfer of 
Legionella chromosomal virulence genes by conjugal DNA transfer has been demonstrated between 
two L. pneumophila strains (Miyamoto et al., 2003).  
 Another key feature of the L. pneumophila genomes is the presence of many genes encoding 
eukaryotic-like proteins and domains (Newton et al., 2010). This suggests that the functional mimicry 
of eukaryotic pathways is a major survival strategy of these bacteria (Lomma et al., 2009). Genes for 
these eukaryotic-like proteins are thought to have been acquired by horizontal transfer from their 
protozoan host cells (Cazalet et al., 2004). This theory is supported by the fact that L. pneumophila is 
naturally competent for DNA transformation (Stone and Kwaik, 1999). Further evidence of horizontal 
gene transfer is the presence of a G+C bias in Legionella genes with eukaryotic motifs compared to 
other L. pneumophila genes (de Felipe et al., 2005). This bias is indicative of genes that have been 
acquired from another species.  
 
Virulence factors 
 The first L. pneumophila gene that was shown to be necessary for optimal infection of human 
macrophage-like cells was named the macrophage infectivity potentiator (mip) (Cianciotto et al., 
1989). This gene encodes a 24 kDa surface protein with peptidyl-prolyl cis/trans isomerase (PPIase) 
activity which catalyses the cis/trans isomerisation of prolyl peptide bonds in oligopeptides (Fischer et 
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al., 1992). The Guinea pig infection model has shown that the Mip protein contributes to the 
dissemination of L. pneumophila within the lung and to the spleen (Wagner et al., 2007). Mip was also 
shown to bind specifically to collagen and enables the bacteria to cross a barrier of lung epithelial cells 
and extracellular matrix.  
 Another cause of tissue damage during Legionnaires’ disease is the release of the extracellular 
metalloprotease MSP,  which causes tissue necrosis and acute pulmonary damage in guinea pigs 
(Baskerville et al., 1986). In addition, this protease has been shown to inhibit neutrophil chemotaxis 
(Rechnitzer and Kharazmi, 1992). 
 A Type I secretion system (T1SS) was recently shown to be required for host cell entry by L. 
pneumophila (Fuche et al., 2015). Furthermore, this secretion system was found to export the repeats-
in-toxin (RTX) protein RtxA, which is involved in adherence, cytotoxicity and pore formation (Cirillo et 
al., 2001). A Type II secretion system (T2SS) is also required for growth in the lungs of A/J mice (McCoy-
Simandle et al., 2011). The L. pneumophila T2SS has been shown to export multiple effectors and to 
reduce the cytokine response of infected host cells (Tyson et al., 2013). Proteins secreted via the T2SS 
are required for the infection of macrophages and the amoeba Acanthamoeba castellanii. 
 
Type IV secretion systems 
Type IV secretion systems (T4SSs) are multi-subunit protein structures found in several species 
of pathogenic Gram-negative bacteria (Christie et al., 2005). They span both bacterial cell membranes 
and the cell wall, enabling them to facilitate horizontal gene transfer and the secretion of effector 
proteins into eukaryotic cells. They are ancestrally related to bacterial conjugation systems, which 
transfer DNA through the mating pair formation (Mpf) complex (Christie, 2001). However, the T4SSs 
are unique among bacterial secretion systems due to their ability to transfer both proteins and 
nucleoprotein complexes (Juhas et al., 2008). The translocation machinery comprises a set of 26 
proteins, encoded by 26 genes across two loci (Ensminger and Isberg, 2009, Gomez-Valero et al., 
2009). In addition, most T4SSs have three ATPases that power the secretion machinery (Fronzes et al., 
2009).  
The T4SS genes are named using either the prefix vir after those on the Agrobacterium 
tumefaciens Ti plasmid or tra after those on the Escherichia coli F plasmid (Juhas et al., 2008). For 
example, the virB4/traC gene encodes the VirB4/TraC protein, the only subunit found in all T4SSs to 
date (Alvarez-Martinez and Christie, 2009). 
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 Several species of pathogenic bacteria use T4SS-secreted effector proteins to subvert host cell 
physiology through a variety of distinct mechanisms (Christie, 2001). For example, the A. tumefaciens 
T4SS (Figure 2) mediates the transfer of a segment of bacterial oncogenic plasmid into recipient plant 
cells (Vergunst et al., 2000). In Helicobacter pylori, the protein CagA is translocated through a T4SS 
into the mammalian host cell, where it triggers cytoskeletal rearrangements (Segal et al., 1999a). The 
pertussis toxin is secreted through a T4SS in Bordetella pertussis called the pertussis toxin exporter 
(Ptl) (Locht et al., 2011). Inside the mammalian host cell, this five-subunit toxin catalyses ADP-
ribosylation of G proteins, thereby interfering with host cell signalling pathways and metabolism. 
 
Figure 2 Structure of the prototypical A. tumefaciens VirB/D4 T4ASS (Backert and Meyer, 2006). The subunits VirB2 and 
VirB5 form an extracellular pilus (Fronzes et al., 2009). The membrane proteins VirB6, VirB8 and VirB10 are thought to form 
the inner membrane channel. The ATPases VirB4, VirB11 and VirD4 power the translocation of substrates.  
 
 Each of the sequenced L. pneumophila strains contain multiple T4SSs from three main classes: 
Type IVA (T4ASS), Type IVB (T4BSS) and genomic island-associated (GI-T4SS) (Table 1) (Isberg et al., 
2009). T4ASSs are related to the archetypal A. tumefaciens VirB/D4 T4ASS (Vergunst et al., 2000). The 
F-type and P-type T4ASSs encode conjugative pili that facilitate mating (Gomez-Valero et al., 2014). 
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The F-type T4ASS encodes long, flexible pili, whereas the P-type T4ASS encodes short, rigid pili (Lawley 
et al., 2003). The remaining secretion systems are described below. 
 
Table 1 Type IV secretion systems present in 13 Legionella genomes (Gomez-Valero et al., 2014). 
 
Lvh Type IVA secretion system 
The L. pneumophila Lvh T4ASS is encoded by 11 lvh (Legionella vir homologue) genes and 5 lvr 
(Legionella vir region) genes (Figure 3) (Segal et al., 1999b). This secretion system has been identified 
in 147 of 217 L. pneumophila strains, including Philadelphia-1, Paris and Lens (Cazalet et al., 2008). 
 
Figure 3 Genetic organisation of the L. pneumophila Lvh T4ASS (Schroeder et al., 2010). The T4ASS subunits are encoded by 
lvr genes (lvrA, -B, -C, -D and –E) and lvh genes (lvhB2, -B3, -B4, -B5, -B7, -B6, -B8, -B9, -B10, -B11 and -D4). The gene prpA1 
encodes a putative phage repressor protein (Samrakandi et al., 2002). 
 
 Although the Lvh T4ASS is not essential for multiplication within macrophages, it has been 
found more frequently in strains associated with human disease (Hilbi et al., 2001, Samrakandi et al., 
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2002). This secretion system is also required for entry and intracellular multiplication in dot/icm 
mutants following conditions designed to mimic the spread of L. pneumophila from water and 
amoebae (Bandyopadhyay et al., 2007). 
In the Philadelphia-1 strain, the lvh region is found in a plasmid-like element of 45kb that is 
present either within the chromosome or in circular episomal form (Chien et al., 2004). Similarly, in 
the Paris strain, the lvh region is encoded in a 36kb region that is either integrated in the chromosome 
or excised as a multicopy plasmid (Cazalet et al., 2004). One study found that the chromosomal 
integration of the plasmid was growth-phase dependent, occurring during the exponential phase 
(Doléans-Jordheim et al., 2006). 
 
Dot/Icm Type IVB secretion system 
 The Dot/Icm T4BSS has been described as the essential virulence determinant of L. 
pneumophila (Harding et al., 2012). It is encoded by the dot/icm genes, which were characterised by 
two different groups between 1992 and 1993 (Figure 4) (reviewed in Rolando and Buchreiser, 2014). 
The dot (defective in organelle trafficking) locus was shown to be crucial for intracellular growth, 
organelle recruitment and inhibition of phagosome-lysosome fusion (Berger and Isberg, 1993). 
Similarly, the icm (intracellular multiplication) locus is necessary for intracellular replication in human 
macrophages (Marra et al., 1992). Since then, the L. pneumophila Dot/Icm T4BSS has also been shown 
to be required for LCV biogenesis and the secretion of many effector proteins into the host cell 
(Allombert et al., 2013). 
 
Figure 4 Genetic organisation of the L. pneumophila Dot/Icm T4BSS (Schroeder et al., 2010). The T4BSS subunits are 
encoded by icm genes (icmT, -S, -R, -Q, -P, -O, -N, -M, -L, -K, -E, -G, -C, -D, -J, -B, -F, -H, -V, -W and -X) and dot genes (dotV, -
D, -C, -B and -A). These are located at 5 loci across 2 distinct regions of the chromosome. The gene lvgA is thought to 
encode a virulence protein (Edelstein et al., 2003). 
 
The genes encoding the Dot/Icm T4BSS are constitutively expressed by L. pneumophila inside 
human macrophages and when cultured in AYE broth (Faucher et al., 2011). However, the genes 
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encoding several translocated effector proteins are strongly induced inside human cells, as 64% of the 
known Dot/Icm effector proteins are induced during intracellular growth. 
 
Dot/Icm T4BSS-secreted effector proteins 
At least 275 bacterial effector proteins are secreted via the L. pneumophila Dot/Icm T4BSS 
(reviewed in Prashar and Terebiznik, 2015). Some of these Dot/Icm effector proteins associate with 
the LCV and recruit host proteins involved in trafficking (Newton et al., 2010). For example, SidM (also 
called DrrA) is a Dot/Icm effector involved in the recruitment of ER-derived vesicles to the LCV 
membrane (Prashar and Terebiznik, 2015). After translocation into the host cell, SidM becomes 
anchored to PI(4)P on the cytoplasmic face of the LCV membrane (Brombacher et al., 2009). It then 
binds specifically to the host protein Rab1 and catalyses Rab1 activation (Ninio and Roy, 2007). As 
Rab1 regulates vesicle trafficking from the ER to the Golgi, this interaction mediates the fusion of the 
ER and LCV membranes (Prashar and Terebiznik, 2015). 
Ankyrin B (AnkB) is the only Dot/Icm effector that has been shown to be essential for L. 
pneumophila proliferation inside both macrophages and protozoan host cells (Price et al., 2009). AnkB 
anchors to the cytosolic face of the LCV membrane, where it interacts with the host SCF1 ubiquitin 
ligase complex to generate polyubiquitinated proteins (Price et al., 2010). The ubiquitin-proteasome 
system then recognises the ubiquitin chains and degrades the associated proteins, generating amino 
acids for intracellular bacterial proliferation (Price et al., 2011). 
After translocation into the host cell, the Dot/Icm effector SidK specifically interacts with the 
catalytic unit of the host vacuolar ATPase, the enzyme responsible for organelle acidification (Xu et 
al., 2010). This interaction inhibits ATP hydrolysis and proton translocation, thereby preventing 
acidification of the LCV.  
 RomA (also called LegAS4) is a Dot/Icm effector with methyltransferase activity that modifies 
the epigenetic state of host cell chromatin (Li et al., 2013). This effector contains an evolutionarily 
conserved eukaryotic motif called the SET domain, found in proteins that modulate gene activity 
(Jenuwein et al., 1998). Inside the host cell, RomA localises to the nucleus, where it methylates lysine 
14 (K14) of histone H3, thereby repressing gene expression (Rolando et al., 2013). Nearly 5,000 H3K14 
methylated promoter regions have been identified, including those involved in innate immunity. 
Furthermore, RomA deletion mutants show significantly reduced replication in host cells (Rolando et 
al., 2013).  
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 Other host cell targets of the effector proteins include GTPases, protein translation and 
ubiquitination pathways (Newton et al., 2010, Isberg et al., 2009). However, there is thought to be 
considerable functional redundancy among the effectors as inactivation of individual effector genes 
rarely causes a severe defect in intracellular replication (Newton et al., 2010). 
 
Genomic island-associated T4SS 
Genomic islands are large chromosomal regions that form mobile genetic elements and are 
thought to play an important role in the evolution and adaptation of bacteria as they enable new traits 
to be acquired rapidly (Dobrindt et al., 2004). It has been suggested that these elements may have 
evolved from bacteriophages or plasmids. Some are referred to as pathogenicity islands as they are 
found more frequently in pathogenic variants than non-pathogenic variants (Dobrindt et al., 2004). 
GI-T4SSs are located within genomic islands and encode the conjugation machinery required 
for transfer of the associated element (Wee et al., 2013). Therefore they enable genomic islands to 
mobilise and spread through a bacterial population, playing a key role in bacterial virulence, evolution 
and adaptation (Juhas et al., 2008). Despite strong conservation of the GI-T4SS, there are significant 
differences in the mobility and expression of the genomic islands harbouring these genes.  
The GI-T4SS was first identified on the genomic island ICEHin1056, a vector encoding antibiotic 
resistance in Haemophilus influenza (Juhas et al., 2007). This GI-T4SS forms a conjugative pilus that is 
responsible for the transfer of the genomic island. GI-T4SSs have since been found in several other 
species, including Pseudomonas aeruginosa, Salmonella enterica and Salmonella bongori (Juhas et al., 
2008).  
In P. aeruginosa, the genomic island pKLC102 contains a cluster of pil genes, which encode 
Type IV thin sex pili (Klockgether et al., 2004). The virulent P. aeruginosa strain PA14 also contains a 
pathogenicity island called PAPI-1 (Harrison et al., 2010). This encodes a Type IVB pilus that transfers 
PAPI-1 into recipient P. aeruginosa strains during co-culture (Carter et al., 2010).  
The S. enterica serovar Typhi has a pathogenicity island called SPI-7 which contains an operon 
encoding Type IV pili (Zhang et al., 2000). These pili are used for entry into human intestinal epithelial 
cells. A related genomic island called ICESb1 has been identified in S. bongori (Seth-Smith et al., 2012). 




 Legionella GI-T4SSs (LGI-T4SSs) are substantially divergent from other GI-T4SSs and represent 
a novel clade of GI-T4SSs only found in this genus (Wee et al., 2013). Nevertheless, they are highly 
conserved across Legionella strains. LGI-T4SSs were found in eight of the nine Legionella genome 
sequences publicly available in 2013, including those of L. pneumophila, L. longbeachae and L. 
drancourtii. Furthermore, the genomes of L. pneumophila Paris, Corby and 130b were found to encode 
two distinct LGI-T4SSs, denoted LGI-1 and LGI-2. The LGI-T4SS gene cluster was found to be associated 
with several cargo genes, including those encoding antibiotic resistance and virulence factors.  
The LGI-T4SS cluster consists of 24 genes, designated lvrRABC and lgiA-T (Figure 5) (Wee et 
al., 2013). At the 5’ end of the LGI-T4SS cluster, the first four genes (lvrRABC) form a regulatory module 
unique to Legionella. This sequence of genes is also present upstream of the Lvh, P-type and F-type 
T4ASSs in Legionella, suggesting a role in coordinating the T4SS expression. 
 
Figure 5 Genetic organisation of the LGI-T4SS (Wee et al., 2013).  
 
The lvrR gene encodes domains that are homologous to those involved in the regulation of 
SOS-response genes in Escherichia coli (Wee et al., 2013). In addition, the protein encoded by lvrC is a 
homologue of CsrA, a protein that regulates the change between the expression of replicative and 
transmissive traits (Gomez-Valero et al., 2011, Molofsky and Swanson, 2003). This suggests that the 
associated genomic island may be excised during a specific growth phase or in response to certain 
conditions.  
A continuous stretch of 20 genes (lgiA-T) is well conserved across all 14 LGI-T4SS clusters (Wee 
et al., 2013). Thirteen of these lgi genes are homologous to genes found in other previously 
characterised GI-T4SSs such as ICEHin1056, and the gene order is largely conserved. Of these 
homologous genes, only nine shared some sequence similarity with genes encoding well characterised 
T4SS subunit proteins: PilL, TraG, TraW, TraB, TraC, TraU, PilT, TraG and TraD. These nine subunits play 
important roles in the formation and stabilisation of the conjugative pilus, as well as providing an 
energy source via ATPases for the assembly of the T4SS complex.  
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The LGI-T4SSs are all located on genomic islands, where they are flanked by variable genomic 
regions (Wee et al., 2013). This indicates multiple insertion, deletion and translocation events, typical 
of genomic islands and other mobile genetic elements. The LGIs are all found within hypervariable 
regions of the genome, adjacent to tRNA genes, which are typical recognition sites for site-specific 
recombinases such as integrases and transposases, suggesting that these regions are hotspots for the 
acquisition of horizontally acquired DNA. 
The conservation of the LGI-T4SS cluster as a predominantly intact stretch of at least 20 genes 
suggests that it plays an important role in the life cycle of Legionella (Wee et al., 2013). To show that 
these genes are being maintained by selection, rather than evolving neutrally, selection analyses have 
been performed on alignments of 15 conserved genes, estimating the ratio of the rate of non-
synonymous substitutions per non-synonymous site (dN) to the rate of synonymous substitutions per 
synonymous site (dS) for each gene (Wee et al., 2013). Genes that are evolving neutrally, suggesting 
that they are not beneficial, are expected to have a dN/dS ratio of one or close to one, whereas genes 
that are evolving under selection pressures, suggesting that they are beneficial, should have a dN/dS 
ratio of significantly less than one. It was found that all 15 genes in the LGI-T4SS clusters have a dN/dS 
that is significantly less than one (p<0.01). This provides further evidence that the LGI-T4SSs have been 
evolving under selection pressures, and may therefore be beneficial to the survival of Legionella. 
The LGI-T4SS of L. pneumophila strain Corby is located on a Legionella genomic island (LGI-2) 
that can undergo horizontal transfer by conjugation and is integrated into a specific site of the 
recipient genome (Lautner et al., 2013). These findings indicate that this LGI-T4SS encodes a functional 
conjugation system. 
 
Edinburgh 2012 Legionnaires’ disease outbreak 
From May to June 2012, there were 50 confirmed and 49 suspected cases during an outbreak 
of Legionnaires’ disease in Edinburgh (McCormick et al., 2012). Of these cases, 3 were fatal and 71 
required hospital care. Although the source of the outbreak has not been established, it is thought to 
have originated from nearby cooling towers. The 2012 Edinburgh outbreak was caused by several 
genetic subtypes of L. pneumophila Sg1, mAb subgroup Knoxville, sequence type (ST)191 (McAdam et 
al., 2014). Whole genome sequencing and phylogenetic reconstruction revealed four distinct subtypes 
(A to D) among the isolates from 15 patients (Figure 6). For patients 10, 11 and 15 the multiple isolates 
obtained from each were identical, suggesting that the short incubation periods did not support 
extensive within-host diversification. The short timescale between exposure to and isolation of the 
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pathogen during the outbreak and the lack of person-to-person transmission for L. pneumophila 
strongly suggest that the genetic subtypes of ST191 existed in the outbreak source prior to release.  
Therefore it is likely that the subtypes evolved from a recent progenitor within the water reservoir by 
a combination of gene mutation, recombination and horizontal gene transfer. 
 
Figure 6 Maximum likelihood un-rooted radial phylogeny of outbreak isolates, showing the distribution of T4SS variants 
across subtypes A to D (McAdam et al., 2014). Maximum likelihood bootstrap values are displayed for each node. Coloured 
triangles indicate multiple isolates from the same patient. 
 
Several regions of difference were identified among the isolates examined, including three 
genetic elements encoding T4SSs (McAdam et al., 2014). The authors found that all nine isolates in 
one clade contained an Lvh T4ASS which shared 100% nucleotide identity with a genetic element in 
the genome of the Philadelphia 1 strain, derived from the original Legionnaire’s disease outbreak in 
Philadelphia in 1976. However, isolates belonging to clades C and D had a novel T4SS-like region not 
present in the genomes of the other outbreak isolates (Figure 7). This region contains 46 predicted 
coding sequences, including homologues of lvrA, lvrB, lvrC and virB, suggesting a possible role as a 
novel T4SS. Additionally, all isolates contained a copy of the T4BSS encoding the Dot/Icm system, but 
a high density of polymorphic sites at the dotA/icmVWX locus differentiated the Dot/Icm T4BSS into 




Figure 7 Schematic diagram of the novel T4SS region present in isolates from clades C and D (McAdam et al., 2014). Arrows 
represent predicted coding sequences. 
 
Variation in the complement of T4SSs encoded by different genetic subtypes was shown to 
correlate with virulence in a Galleria mellonella model of infection (Figure 8) (McAdam et al., 2014). 
Considerable strain-dependent variation in G. mellonella host survival was observed after infection, 
and a significant difference in killing capacity was identified between groups of isolates with unique 
combinations of T4SSs. In particular, strains with the novel putative T4SS resulted in more rapid killing 
of G. mellonella larvae than strains without it. There was no significant difference between isolates 
containing different variants of the Dot/Icm T4SS  
The small number of patients infected with the subtype containing the novel T4SS was not 
sufficient for a robust statistical analysis and there was no statistically significant difference in clinical 
disease indicators between patients infected with strains containing the novel T4SS and those infected 
with strains lacking the novel T4SS (McAdam et al., 2014). However, patients with the novel T4SS 
required more clinical care intervention, including higher intensive care unit (ICU) admission, a higher 
proportion requiring mechanical ventilation, and fewer ICU-free days.  
The molecular mechanisms underlying the virulence of strains harbouring the novel T4SS are 
unknown. This project aims to address the hypothesis that this system provides L. pneumophila with 





Figure 8 Virulence of outbreak isolates in G. mellonella model of infection (McAdam et al., 2014). Survival curves represent 
the mean for isolates grouped according to the presence of each T4SS. Larvae infected with isolates encoding the novel 






Aims and objectives 
Aim: To determine the role of a novel Type IV secretion system in the increased virulence of clade C 
and D L. pneumophila isolates. 
A novel Type IV Secretion System (T4SS) was identified in patient isolates from the Edinburgh 
Legionnaire’s disease outbreak in 2012 (McAdam et al., 2014). A phylogenetic reconstruction of the 
isolates shows four distinct subtypes, two of which share a region thought to encode a novel T4SS. In 
a Galleria mellonella infection model, the presence of this T4SS correlated with increased virulence. 
This project aims to dissect the role of the novel T4SS in intracellular survival using a macrophage 
model of infection.  
Objectives: 
 Perform a bioinformatics analysis of the novel genes to identify possible origins and functions. 
 Detect the expression of novel genes in broth culture and infected macrophage-like cells. 
 Compare intracellular replication rates of Legionella from each clade. 




Chapter 2: Materials and methods 
Bioinformatics 
Identification of genes unique to clades C and D 
 Orthologous genes between the representative isolates listed below were defined using the 
OrthoMCL algorithm (Li et al., 2003) with the following parameters: minimum 80% coverage in BLAST 
pairwise alignments, minimum 85% sequence identity in BLAST query/subject pairs, filtered by 50% 
length difference within clusters. Unique genes were mapped to the genome of clade D strain 12_4240 
using the DNAPlotter application (Carver et al., 2009). 
Clade Representative isolate Accession number 
A 12_5415 NZ_CCZU00000000 
B 12_5064 NZ_CCZP01000000 
C 12_4499 NZ_CDCY00000000 
D 12_4240 NZ_CCZI00000000 
 
Analysis of the novel T4SS 
 Pairwise nucleotide sequence identity analyses of the T4SS and 39-kb region were performed 
using the Basic Linear Alignment Search Tool (BLASTn) (http://www.ncbi.nlm.nih.gov/blast) (Altschul 
et al., 1990). Linear comparison figures were generated using EasyFig (Sullivan et al., 2011). The LGI-
T4SS phylogenetic tree was constructed using the BLAST tree view 
(http://www.ncbi.nlm.nih.gov/blast/treeview/treeView.cgi). The strains used are listed below. 
 
 
Species Strain Accession number LGI-T4SS LGI-T4SS locus tags 
L. pneumophila Paris CR628336.1 LGI-1 lpp1075 - lpp1055 
 12_4240 NZ_CCZI00000000 39-kb region PROKKA_00671 – 
PROKKA_00693 
L. longbeachae D-4968 NZ_ACZG01000001.1  LLB_1169 – LLB_1191  
Species Strain Accession number LGI-T4SS lgiN locus tag 
L. pneumophila Alcoy CP001828 LGI-1 lpa_01507 
Corby CP000675 LGI-1 LPC_2290 
LGI-2 LPC_1874 
Philadelphia 1 AE017354 LGI-1 lpg0989 




39-kb region PROKKA_00687 
50-kb region PROKKA_01789 
L. longbeachae D-4968 NZ_ACZG01000001.1  LLB_1185  
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Prediction of T4SS-secreted effector proteins and eukaryotic-like motifs 
 The classifier T4EffPred was used to predict whether or not each of the 31 genes unique to 
clade C and D encode T4SS effector proteins (http://bioinfo.tmmu.edu.cn/T4EffPred/prediction.html) 
(Zou et al., 2013). The eukaryotic linear motif resource ELM was used to identify any eukaryotic motifs 
present in the seven predicted T4SS effector proteins (http://elm.eu.org) (Dinkel et al., 2013). 
 
Bacteriology 
Growth of representative L. pneumophila isolates 
 The L. pneumophila isolates were resuscitated from frozen glycerol stocks on BCYE agar plates 
(CYE agar plates with Legionella BCYE growth supplement (VWR Chemicals)) at 37°C for 48 hours, then 
cultured in broth (0.5% yeast extract, 1% bovine serum albumin and Legionella BCYE growth 
supplement) at 37°C with shaking.  
 
Triton X-100 assay 
 A broth culture of L. pneumophila Paris was diluted in broth to an OD600 of 0.5 (approximately 
109 bacteria/ml) using the Utrospec 2100 pro UV/visible spectrophotometer (Amersham Biosciences), 
then further diluted in broth to approximately 106 bacteria/ml. 1ml of the diluted culture was added 
to 3 microcentrifuge tubes, then centrifuged at 13,000 x g for 1 minute. The resulting pellets were 
resuspended in 1ml of either 0%, 0.05% or 0.1% Triton X-100 in PBS. After incubation for 5 minutes at 
room temperature, each suspension was serially diluted in PBS, then 10μl of each dilution was plated 
on BCYE agar. The plates were incubated at 37°C until colonies were visible. 
 
Growth curve in broth culture 
 L. pneumophila isolates from glycerol stocks were resuscitated on CYE agar plates with 
Legionella BCYE growth supplement (VWR Chemicals) at 37°C for 48 hours, then 3 colonies from each 
strain were cultured in broth at 37°C for 48 hours. OD600 was adjusted to 0.02 in broth or DMEM using 
the Utrospec 2100 pro UV/visible spectrophotometer (Amersham Biosciences). 200µl of each diluted 
sample was added to a 96-well tissue culture plate. Growth was quantified hourly for 4 days by OD600 
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using the FLUOstar Omega microplate reader (BMG LabTech) set at 37°C and shaking. Data was 
analysed by the student’s 2-sample t-test using Minitab® 17 statistical software. 
 
Molecular methods 
CTAB extraction of L. pneumophila genomic DNA 
 Genomic DNA from a representative strain of each clade was extracted. For each strain, 1.5ml 
of overnight culture was centrifuged at 13,000 x g for 5 minutes. After removal of the supernatant, 
the cells were vortexed in 567µl Tris-EDTA buffer (10mM Tris-HCl (pH 8.0) and 1mM EDTA (pH 8.0)). 
The cells were then incubated with 30µl 10% SDS and 3µl 20mg/ml proteinase K at 37°C for 2 hours. 
The sample was mixed with 100µl 5M NaCl and 80µl CTAB/NaCl solution (0.7M NaCl and 274mM 
hexadecyltri-methyl ammonium bromide; filter sterilised), then incubated at 65°C for 10 minutes. The 
sample was mixed with 750µl phenol:chloroform:isoamyl alcohol then centrifuged at 13,000 x g for 
30 minutes. The aqueous supernatant was mixed with 750µl phenol:chloroform:isoamyl alcohol then 
centrifuged at 13,000 x g for 25 minutes. The aqueous supernatant was mixed with 750µl 
phenol:chloroform:isoamyl alcohol then centrifuged at 13,000 x g for 15 minutes. The aqueous 
supernatant was mixed with 450µl isopropanol then centrifuged at 13,000 x g for 10 minutes. After 
removal of the supernatant, the pellet was centrifuged with 400µl 70% ethanol at 13,000 x g for 10 
minutes. The supernatant was removed and the pellet air dried. The pellet was resuspended in 50µl 
sterile distilled water. RNase was added to a final concentration of 10µg/ml, then the sample was 
incubated at room temperature for 20 minutes. The quantity and quality of the resulting DNA samples 
was assessed using the NanoDrop ND-1000 Spectrophotometer (Thermo Scientific). 
 
PCR validation of primers using genomic DNA 
PCR reactions were performed in 20µl volumes using the G-Storm GS001 thermal cycler. The 
reaction mix contained Phusion HF buffer (Thermo Scientific), 0.2mM deoxynucleotides, 1µM forward 
primer, 1µM reverse primer, 0.4 units Phusion DNA polymerase (Thermo Scientific) and 0.5ng 
template DNA in nuclease-free water. After an initial denaturation step at 98°C for 2 minutes, thirty 
cycles of amplification were performed under the following conditions: denaturation at 98°C for 10 
seconds, annealing at 64°C for 20 seconds and extension at 72°C for 10 seconds. The final extension 




Gene Forward primer Reverse primer 
icmQ GAAAGATCAACTCTCGGATGAACAAAAAG CGATTGGCAAGATGAGACTCTGCTTTTAAC 
lgiA GAAATTATTATTTGTTACTTCTCTTGGCTTC GAATATTTAAGCCACCATTCAAGAGCTTGG 
lgiD CTCTATTATTGCAGGCTTATTGATGATTAC GTTAGTTAGTTCGAGTTTTCGTCTTTCCAC 
lgiT GAGCCATTATCCCGTTGAAAACTTGCT GATAGCGTTTTATTTTAAATGCCTGAACTC 
00662 CAAAATCCAGAATCAGACCGGCAACTTC CGTCCTAGAGTATAAGTACGATAACCATC 
00663 GGATCTAACTATAGACCCTATTACAAAGCG CATCCTTATTATCAATACCGATTAGTTCTC 
00666 GAACAAGATTTGTAAAGTTTCATGGAAGG CACTTGATGTGGGTAAATAT 
00668 GGGATGTATAGCCGAATTTTTGGCATCAG GTTTTTGTACTGTCCAGATAGTCTTTACCAC 
00669 CAAAAATTCAGATTATTTAACGAGCACCCC GTCCACAGATATGTCTTCGATGTGAAGATTC 
00697 GATAGAGTTACTAAAAATTCTAATCTCTTCGG CTCTGCCGTATGTATGTTCAGGTAAATATC 
 
Extraction of RNA from L. pneumophila clade C and D isolates 
 RNA from isolates 12_4499 and 12_4240 grown in either broth or infected RAW 264.7 cells 
was isolated using the Reliaprep™ RNA Cell Miniprep System (Promega) according to the product 
technical manual. The quantity and quality of the resulting RNA samples was assessed using the 
NanoDrop ND-1000 Spectrophotometer (Thermo Scientific). 8µl of each RNA sample was then 
incubated with 1µl RNase-free DNase (Promega) and 1µl RNase-free reaction buffer (Promega) at 
37°C for 30 minutes. The samples were then incubated with 1µl DNase Stop Solution (Promega) at 
65°C for 10 minutes. 
 
Reverse transcription-PCR 
 Reverse transcription-PCR (RT-PCR) reactions were performed in 50µl volumes using the 
Access RT-PCR System (Promega) and G-Storm GS001 thermal cycler. The reaction mix contained 
AMV/Tfl reaction buffer, 0.2mM deoxynucleotides, 1µM forward primer, 1µM reverse primer, 1mM 
MgSO4, 0.1u/µl AMV reverse transcriptase, 0.1u/µl Tfl DNA polymerase and 5ng template RNA in 
nuclease-free water. Reverse transcription was performed at 45°C for 45 minutes, followed by reverse 
transcriptase inactivation and nucleic acid denaturation at 94°C for 2 minutes. Thirty cycles of 
amplification were then performed for RNA samples from isolates grown in broth, and 50 cycles were 
performed for RNA samples from infected RAW 264.7 cells. Templates were denatured at 94°C for 30 
seconds, primers annealed at 60°C for 1 minute and extension performed at 68°C for 1 minute. The 





Agarose gel electrophoresis 
 PCR and RT-PCR products were resolved in a 1.8% agarose gel with 1% Syber safe DNA stain 
(Invitrogen) in TAE buffer (40mM Tris-acetate and 1Mm EDTA; pH 7.7). A 100bp DNA ladder (Promega) 
was loaded into one lane and DNA loading dye (Invitrogen) was added to all samples before loading. 
Electrophoresis was performed in a Bio-Rad Mini-Sub® Cell at a constant voltage of 100V. DNA was 
visualised using the FluorChem HD2 imaging system (Alpha Innotech). 
 
Extraction of DNA from infected RAW 264.7 cells for qPCR  
Each cell pellet was resuspended in 100µl 0.4mg/ml lysozyme in Tris-EDTA with 1.2% Triton X-
100 (Sigma-Aldrich), then incubated at 37°C for 30 minutes prior to DNA extraction using the QIAamp® 
DNA Mini Kit (Qiagen). The quantity and quality of the resulting DNA samples was assessed using the 
NanoDrop ND-1000 Spectrophotometer (Thermo Scientific). 
 
Real-time qPCR optimisation 
 Preliminary amplification and dissociation plots were generated to test all possible pairings of 
primer concentrations for IcmQ and β-actin, listed below. For each primer pair, qPCR reactions were 
performed in 10µl volumes containing Brilliant III Ultra-Fast SYBR Green qPCR master mix (Agilent 
Technologies), 30nM reference dye (Agilent Technologies), 10ng DNA sample in nuclease-free water 
and both forward and reverse primers at either 0.1µM, 0.2µM or 0.3µM. Fifty cycles of amplification 
were performed using the Stratagene Mx3000P qPCR system (Agilent Technologies) under the 
following conditions: denaturation at 95°C for 10 seconds, then annealing, extension and read 
fluorescence at 60°C for 22 seconds. This was followed by a dissociation curve in which the PCR 
products were subjected to a stepwise increase in temperature from 60°C to 95°C to determine their 
melting temperature. Results were analysed using the MxPro qPCR software (Agilent Technologies). 
Gene Forward primer Reverse primer 
icmQ GAAAGATCAACTCTCGGATGAACAAAAAG CGATTGGCAAGATGAGACTCTGCTTTTAAC 







 qPCR reactions were performed in 10µl volumes containing Brilliant III Ultra-Fast SYBR Green 
qPCR master mix (Agilent Technologies), 0.2µM (β-actin) or 0.3µM (icmQ) forward and reverse 
primers, 30nM reference dye (Agilent Technologies) and 10ng DNA sample in nuclease-free water. 
Fifty cycles of amplification were performed using the Stratagene Mx3000P qPCR system (Agilent 
Technologies) under the following conditions: denaturation at 95°C for 10 seconds, then annealing, 
extension and read fluorescence at 60°C for 22 seconds. Results were analysed using the MxPro qPCR 




Cell infection assay  
 At 24 hours prior to infection, 24-well tissue culture plates were seeded with 1x106 RAW 264.7 
cells in 10% DMEM (Dulbecco’s Modified Eagle’s Medium with 10% heat-inactivated fetal calf serum), 
then incubated at 37°C with 5% CO2. At 21 hours prior to infection, existing broth cultures of the 
required L. pneumophila strains at stationary phase were diluted in broth to an OD600 of 0.1 using the 
Utrospec 2100 pro UV/visible spectrophotometer (Amersham Biosciences) then incubated at 37°C 
with shaking. 
 Immediately prior to infection, each L. pneumophila broth culture was adjusted to an OD600 of 
0.5 (approximately 109 bacteria/ml) in broth, then diluted in 10% DMEM to provide the required 
multiplicity of infection (MOI). DMEM was removed from each well of the tissue culture plates and 
replaced with the diluted L. pneumophila cultures. A gas-permeable membrane was applied to each 
plate before centrifugation at 20 x g for 5 minutes, then incubation at 37°C with 5% CO2 for 1 hour. 
Media was removed from the plates and the wells were washed three times with phosphate-buffered 
saline (PBS). 100µg/ml gentamicin in 10% DMEM was added to each well before incubation at 37°C 
for 1 hour. Media was removed from the plates and the wells were washed three times with PBS. 10% 
DMEM was added to each well before further incubation at 37°C with 5% CO2 until the required time 





Gentamicin protection assay with representative L. pneumophila isolates for qPCR 
As described previously, tissue culture plates seeded with RAW 264.7 cells were inoculated 
with bacteria at an MOI of 1. A gas-permeable membrane was applied to each plate before 
centrifugation at 20 x g for 5 minutes, then incubation at 37°C for 30 minutes (0-hour timepoint) or 1 
hour (2-, 4- and 24-hour timepoints). After 30 minutes, the media was removed from one plate and 
2ml PBS was added to each well. Cells were scraped into suspension, transferred to microcentrifuge 
tubes and centrifuged at 900 x g for 5 minutes. The supernatant was removed and the pellet 
(representing the 0.5 hour timepoint) frozen for DNA purification.  
After 1 hour, media was removed from the remaining plates and replaced with 100µg/ml 
gentamicin in 10% DMEM before incubation at 37°C for 1 hour. Media was removed from the 
remaining plates and the wells were washed three times with PBS. 10% DMEM was added to each 
well before incubation at 37°C for a further 1, 3 or 23 hours (2-, 4- and 24-hour timepoints, 
respectively). Media was removed from the plates and 2ml PBS was added to each well. Cells were 
scraped into suspension, transferred to microcentrifuge tubes and centrifuged at 900 x g for 5 
minutes. The supernatant was removed and the pellet frozen for DNA purification.  
 
Cell cytotoxicity assay 
 As described previously, four 6-well tissue culture plates seeded with 5x106 RAW 264.7 cells 
per well were inoculated with either representative L. pneumophila isolates (MOI = 1) or 10% DMEM 
(uninfected control). The final incubation step was performed with 2ml 10% phenol red-free DMEM 
(phenol red-free DMEM with 10% heat-inactivated fetal calf serum) in each well. At 2, 4 and 24 hours 
post-infection, 200µl 10X Lysis Solution (Promega) was added to one well for 45 minutes (positive 
control), then 1ml supernatant from each well was transferred to microcentrifuge tubes. These were 
centrifuged at 300 x g for 4 minutes, then the resulting supernatant was used in the cell cytotoxicity 
assay. This assay was performed using the CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega) 
according the manufacturer’s instructions. Absorbance at 490nm was measured using the FLUOstar 
Optima microplate reader (BMG LabTech). Data was analysed by the student’s 2-sample t-test using 





Protein detection methods 
Cell lysate samples 
 As described previously, four 6-well tissue culture plates seeded with 5x106 RAW 264.7 cells 
per well were inoculated with either representative L. pneumophila isolates (MOI = 1) or 10% DMEM 
(uninfected control). At 2, 4 and 24 hours post-infection, the media was removed and the wells were 
washed twice with PBS. 50µl BugBuster™ Protein Extraction Reagent (Novagen) was added to each 
well, then the plates were incubated at room temperature for 10 minutes. The resulting cell lysates 
were incubated with 10µl reducing sample treatment buffer (RSTB) at 90°C for 10 minutes, then 
centrifuged at 13,000 x g for 1 minute. 
 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
2µl Precision Plus Protein WesternC Protein Standards (Bio-Rad) and 15 µl of each cell lysate 
sample were loaded into a 12.5% 1.5 mm SDS-polyacrylamide gel. Gels were submerged in running 
buffer (25 mM Tris-HCL, 192 mM glycine, 0.1% SDS) and run at 150V with Bio-Rad Mini-PROTEAN Tetra 
Cell apparatus. 
 Resolving gel Stacking gel 
30% Acrylamide  4.17ml 850µl 
2% Bis-acrylamide 500µl 350µl 
1M Tris (pH 8.8) 3.75ml  
1M Tris (pH 6.8)  625µl 
10% SDS 100µl 50µl 
Distilled water 1.5ml 3.25ml 
Tetramethylethylenediamine (TEMED) 8.35µl 12.5µl 
10% Ammonium persulphate in water 33.35µl 25µl 
 
Western blotting 
 Protein was transferred from the SDS-polyacrylamide gel to a nitrocellulose membrane (GE 
Healthcare Life Science) using the Bio-Rad Trans-Blot Turbo transfer system at 25V for 30 minutes in 
transfer buffer (25mM Tris-HCl, 192mM glycine, 20% methanol). Following transfer, membranes were 
blocked in PBS with 5% non-fat dry milk for 30 minutes. After 3 washes in PBS with 0.1% Tween 20 
(PBS-T), membranes were incubated with primary antibody (0.2µg/ml rabbit anti-LC3 and 0.1µg/ml 
goat anti-actin (Santa Cruz Biotechnology)) at 4°C overnight. After 3 washes in PBS-T, membranes were 
incubated with secondary antibody (1µg/ml anti-rabbit680 (Cell Signalling Technology) and 1µg/ml anti-
goat800 (Li-Cor)) at room temperature for 1 hour. The membranes were washed 5 times in PBS-T, then 
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stored in PBS before imaging with the Li-Cor Odyssey infrared imager and quantification with Li-Cor 




Co-staining RAW 264.7 cells infected with L. pneumophila  
 Coverslips from the infection were washed twice with PBS, then cells were permeabilised with 
0.5% Triton-X100 (Sigma-Aldrich) in PBS for 15 minutes at room temperature. The coverslips were 
washed twice with PBS. Next, non-specific binding sites were blocked with BSA/PBS (0.5% bovine 
serum albumin in PBS with 0.02% sodium azide; filtered through 0.2 µm filter) for 30 minutes at room 
temperature. Coverslips were transferred onto parafilm on wet tissue paper, then each coverslip was 
incubated with 50µl 2 µg/ml FITC-conjugated anti-Legionella antibody (abcam) for 1 hour at 37°C. Each 
coverslip was washed in PBS, then incubated with 50µl 2 U/ml Phalloidin 568 for 15 minutes at room 
temperature. Each coverslip was washed again in PBS, then stained with 9.53 µM DAPI (4’,6-
diamidino-2-phenylindole). The coverslips were then mounted on glass slides with 5 µl ProLong Gold 
(Molecular Probes). 
 
Confocal microscopy of RAW 264.7 cells infected with L. pneumophila  
Coverslips were imaged using a Zeiss LSM 710 confocal microscope and a 40X objective lens. 
Fluorophores were excited with lasers at 405 nm, 488 nm and 543 nm. Images were processed using 




Chapter 3: Analysis of novel Legionella pneumophila genes 
Introduction 
 In order to identify the mechanism underlying the increased virulence of the clade C and D L. 
pneumophila strains, the genes unique to these clades were identified and studied using a 
bioinformatics approach. Some of these unique genes encode the novel T4SS identified by McAdam 
et al. (2014), which was further analysed in order to identify its origin and possible function in the 
isolates. Predicted T4SS-secreted effectors containing eukaryotic-like linear motifs unique to clades C 
and D were also identified. The expression of novel T4SS and putative effector genes was determined 
in Legionella total RNA samples from both broth culture and infected macrophage-like cells using 
reverse transcription-PCR (RT-PCR) to detect mRNA transcripts.   
 
Bioinformatic analysis of novel genes unique to clades C and D 
 One representative L. pneumophila isolate from each of the four clades was chosen for 
bioinformatic analysis, as listed in Table 2. Using the OrthoMCL algorithm (Li et al., 2003), a total of 
149 genes present in Clades C and D were found to be absent from Clade B (Figure 9). Of these, 31 
genes are also absent from Clade A, and therefore unique to Clades C and D. Orthologous genes were 
defined with the following parameters: minimum 80% coverage in BLAST pairwise alignments, 
minimum 85% sequence identity in BLAST query/subject pairs, filtered by 50% length difference within 
clusters. 
Clade Representative isolate Accession number 
A 12_5415 NZ_CCZU00000000 
B 12_5064 NZ_CCZP01000000 
C 12_4499 NZ_CDCY00000000 
D 12_4240 NZ_CCZI00000000 
Table 2 Representative L. pneumophila isolates used in this study.  
 
 The 39-kb region shown in Figure 9 was investigated further as it is unique to clades C and D, 
and may therefore be linked to the increased virulence of these clades in a Galleria model (McAdam 
et al., 2014). This region and the surrounding genome encode several features that are commonly 
associated with pathogenicity islands, including integrases, transposases and tRNA (Figure 10) (Hacker 
et al., 1997). Furthermore, the G+C content of the region (37.45%) is slightly lower than that of the 
rest of the genome (38.94%). These features suggest that the 39-kb region may be a functional 




Figure 9 Distribution of genes absent from Clade B (black) or absent from both Clades A and B (red). Mapped to genome of 
clade D strain 12_4240 (orange) using the DNAPlotter application (Carver et al., 2009). Label indicates the 39-kb region 
unique to clades C and D.  
  
 
Figure 10 Pathogenicity island features associated with the 39-kb region. Labelled genes encode a transposase (1), 






Novel T4SS of clades C and D 
 The 39-kb region contains the T4SS originally identified by McAdam et al. (2014) as a novel 
Lvh T4ASS (Figure 11). However, pairwise nucleotide sequence identity (BLASTn) analysis revealed that 
this region encodes a LGI-T4SS (Figure 12). The strains and gene clusters used are listed in Table 3. 
Unexpectedly, this LGI-T4SS shares only 75% nucleotide identity and 82% amino acid identity with that 
of L. pneumophila strain Paris, but shares 90% nucleotide identity and 96% amino acid identity with 
the LGI-T4SS of L. longbeachae strain D-4968.  
 
Figure 11 Schematic diagram of the 39-kb region, including the novel T4SS identified by McAdam et al. (2014). Arrows 
represent predicted CDSs identified using the Prokka annotation pipeline (Seemann, 2014). 
 
 
Figure 12 Linear comparison of LGI-T4SS clusters. Arrows represent coding sequences. Shaded bars between each cluster 
represent nucleotide sequence identity (BLASTn). Generated using EasyFig (Sullivan et al., 2011). 
 
Table 3 Strains and LGI-T4SS gene clusters used in the BLASTn analysis. 
 
Species Strain Accession number LGI-T4SS LGI-T4SS locus tags 
L. pneumophila Paris CR628336.1 LGI-1 lpp1075 - lpp1055 
 12_4240 NZ_CCZI00000000 39-kb region PROKKA_00671 – 
PROKKA_00693 
L. longbeachae D-4968 NZ_ACZG01000001.1  LLB_1169 – LLB_1191  
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 A phylogenetic tree was constructed using BLAST pairwise alignments of the lgiN gene 
nucleotide sequence, which encodes a putative ATPase within the LGI-T4SS cluster (Figure 13) (Wee 
et al., 2013). The strains and genes used are listed in Table 4. The phylogenetic tree shows that the 
39-kb T4SS is closely related to the L. longbeachae D-4968 LGI-T4SS. Therefore, the novel T4SS appears 
to be an LGI-T4SS that has originated from L. longbeachae. 
 
Figure 13 Unrooted phylogenetic tree of LGI-T4SSs across L. pneumophila (Lp) and L. longbeachae (Ll) genomes listed in Table 
4. Tree of lgiN genes using BLASTn pairwise alignments, visualised using the BLAST tree view 
(http://www.ncbi.nlm.nih.gov/blast/treeview/treeView.cgi). 
 
Table 4 Strains and lgiN genes used to construct the phylogenetic tree. 
 
 Researchers from the Fitzgerald laboratory have access to the L. longbeachae genomes of 
patient and environmental isolates from a Legionnaires’ disease outbreak in Scotland in 2013 (Potts 
et al., 2013). BLASTn analysis showed that the entire 39-kb region shares 94% nucleotide identity with 
the homologous region in the L. longbeachae isolate 13_6619, isolated from a compost sample 
provided by a patient of the outbreak (Figure 14). Therefore, the full 39-kb region is likely to have 
originated from L. longbeachae and may have been transferred to L. pneumophila in the environment. 
Species Strain Accession number LGI-T4SS lgiN locus tag 
L. pneumophila Alcoy CP001828 LGI-1 lpa_01507 
Corby CP000675 LGI-1 LPC_2290 
LGI-2 LPC_1874 
Philadelphia 1 AE017354 LGI-1 lpg0989 




39-kb region PROKKA_00687 
50-kb region PROKKA_01789 




Figure 14 Linear comparison between the 39-kb region of L. pneumophila clade D isolate 12_4240 (PROKKA_00662 – 
PROKKA_00706) and the homologous region in the L. longbeachae isolate 13_6619. Shaded bars between each cluster 
represent nucleotide sequence identity (BLASTn). Generated using EasyFig (Sullivan et al., 2011). 
  
Prediction of novel T4SS-secreted effector proteins and eukaryotic-like motifs 
 The classifier T4EffPred was used to predict whether or not each of the 31 genes unique to 
clade C and D encode T4SS effector proteins (http://bioinfo.tmmu.edu.cn/T4EffPred/prediction.html) 
(Zou et al., 2013). T4EffPred identifies putative effectors by scoring proteins according to their amino 
acid composition, dipeptide composition and other distinctive features of T4SS effector proteins. A 
total of 7 genes were predicted to encode T4SS-secreted effectors, all of which are located adjacent 
to the L. longbeachae-like LGI-T4SS in the 39-kb region (Figure 15).  
 
Figure 15 Schematic diagram of the 39-kb region showing location of predicted T4SS secreted effectors. Arrows represent 
predicted CDSs identified using the Prokka annotation pipeline (McAdam et al., 2014). 
 
 Secreted effectors interact with host cell proteins via eukaryotic-like domains, which are 
common features of Legionella T4SS effectors (Lomma et al., 2009). These interactions may promote 
the survival of Legionella and could therefore provide a mechanism for the increased virulence of the 
clade C and D isolates. The eukaryotic linear motif resource ELM was used to identify any eukaryotic 
motifs present in the seven predicted T4SS effector proteins (http://elm.eu.org) (Dinkel et al., 2013). 
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PDZ-binding motif: PDZ domains are involved in protein targeting 
and the assembly of protein complexes (Hung and Sheng, 2002). 
(Interaction domain PF00595) 
   ✓   ✓ 
Clathrin box motif: Binds clathrin heavy chain (Alberts et al., 2008a). 
Found on cargo adaptor proteins. (Interaction domain PF01394) 
✓ ✓ ✓   ✓  
eIF4E binding motif: Binds the dorsal surface of the eukaryotic 
Translation Initiation Factor 4E (eIF4E) (Marcotrigiano et al., 1999). 
Blocks assembly of the translation machinery. (Interaction domain 
PF01652) 
 ✓  ✓    
IAP binding motif: Binds Inhibitor of Apoptosis Proteins (IAPs) in 
apoptotic cells (Vucic and Fairbrother, 2007). (Interaction domain 
PF00653) 
✓  ✓     
SH2 domain motif: Binds phosphorylated tyrosine residues (Koch et 
al., 1991). Involved in signal transduction of receptor tyrosine kinase 
pathways. (Interaction domain PF00017) 
    ✓ ✓  
Table 5 Selected predicted eukaryotic linear motifs in putative T4SS effector proteins. (P < 0.1). 
 
Expression of predicted effectors  
 To determine whether or not the LGI-T4SS and predicted effector proteins are expressed by 
the isolates in either broth culture or during infection of cultured cells, reverse transcription PCR (RT-
PCR) was used to detect mRNA encoding several genes of interest. Bacterial RNA samples were 
extracted from the representative L. pneumophila clade C and D isolates at stationary phase in broth 
culture and infected RAW 264.7 macrophage-like cells using the ReliaPrepTM RNA Cell Miniprep System 
(Promega), according to the product technical manual. The quantity and quality of the resulting RNA 
samples was assessed using the NanoDrop ND-1000 Spectrophotometer (Thermo Scientific). 
 The RAW 264.7 cells were infected using a gentamicin protection assay (see Chapter 2) at an 
MOI of 1. At 18 hours post-infection, media was removed from each well and replaced with 1ml PBS. 




 Several aspects of the RT-PCR protocol were optimised using the gene icmQ, which encodes a 
component of the constitutively expressed Dot/Icm T4BSS (Faucher et al., 2011). For each clade, four 
wells of a 6-well tissue culture plate with a total of approximately 2x107 RAW 264.7 cells were infected 
in order to maximise the yield of RNA for Legionella gene expression to be detected. Infected RAW 
264.7 cells were incubated with 0.4mg/ml lysozyme in Tris-EDTA for 5 minutes prior to RNA extraction 
to increase the yield of RNA. This incubation step increased the yield by 44%, from 15.94μg to 22.94μg 
RNA. In addition, the number of RT-PCR cycles was increased from 30 to 50 for reactions with RNA 
samples from infected cells. This was necessary as these samples also contained RAW 264.7 cell RNA 
and therefore a smaller quantity of bacterial RNA. 
 A negative control reaction without reverse transcriptase (RT) was carried out alongside each 
RT-PCR reaction. This ensured that the PCR reaction only amplified DNA that was produced from the 
reverse transcription of mRNA. Therefore the assay specifically detected transcribed genes only. In 
addition, the RNA samples were treated with RNase-free DNase (Promega) in order to reduce the 
amount of DNA in the negative control reaction (Figure 16). 
 
Figure 16 Optimisation of RT-PCR protocol with DNase treatment. Products of RT-PCR with primers for icmQ and RNA 
extracted from the representative clade A isolate in broth culture. 
 
 Primers were designed for three LGI-T4SS genes (lgiA, lgiD and lgiT) and five genes encoding 
predicted effectors (00662, 00663, 00666, 00669 and 00697) (Figure 17). Each pair of primers was 
designed to produce a DNA product of 200bp in length.  The primers were validated by PCR on 
genomic DNA extracted from representative isolates of each clade to ensure specificity to the unique 




Figure 17 Location of genes within the 39-kb region that were detected using PCR and RT-PCR. 
 
 
Figure 18 PCR validation of primers for genes encoding putative effector proteins on genomic DNA from representative L. 
pneumophila isolates. icmQ is used as a positive control. Negative controls (-) contain no genomic DNA. 
 
 Whilst expression of icmQ could be detected, expression of the putative effector genes was 
not detected in bacteria from broth culture (Figure 19). However, the genes lgiA, lgiD, lgiT, 00662 and 
possibly 00666 appeared to be expressed during intracellular growth (Figure 20). This indicates that 
expression of the LGI-T4SS and the predicted effectors 00662 and 00666 may be induced during 








Figure 20 RT-PCR on RNA extracted from representative Clade C and D isolates from infected RAW 264.7 cells. icmQ was 
used as a positive control. 
 
 Expression of the positive control gene icmQ was not detected in the RNA samples from 
infected cells (Figure 20). It has been shown previously that the expression of icmQ decreases after 3 
hours of infection and is only expressed at a low level by 20 hours post-infection (Barysheva et al., 
2008). As the RNA samples were extracted at 18 hours post-infection, it is likely that icmQ was 
expressed at a low level that was insufficient for detection by RT-PCR. 
 
Summary 
 The genes unique to clades C and D were analysed using a bioinformatics approach. The 39-
kb region unique to these clades was found to resemble a pathogenicity island and unexpectedly, the 
novel T4SS identified by McAdam et al. (2014) was shown to be a LGI-T4SS originating from L. 
longbeachae. Five of the genes adjacent to the LGI-T4SS were predicted to encode T4SS-secreted 
effector proteins and were shown to contain several eukaryotic-like linear motifs. mRNA encoding the 
LGI-T4SS and predicted effectors 00662 (and possibly 00666) was detected in cells infected with 




Chapter 4: Comparing growth rates and host cell response 
Introduction 
 In order to assess any requirement of the novel T4SS in the survival of L. pneumophila, several 
techniques were used to determine the replication rate of isolates from each clade. The infection 
protocol was optimised using L. pneumophila Paris and RAW 264.7 macrophage-like cells, which were 
later infected with representative isolates of each clade. Replication rate in broth culture was 
compared using a microplate reader and intracellular replication was quantified using qPCR. In 
addition, two assays were used to compare cytotoxicity and autophagy in RAW 264.7 cells infected 
with representative isolates from each clade. 
 
Infection optimisation with L. pneumophila Paris 
 A gentamicin protection assay was used to study the intracellular replication of the L. 
pneumophila isolates and the response of infected host cells. The L. pneumophila strain Paris was used 
to optimise the infection protocol before using representative isolates from clades A, B, C and D. The 
mouse leukemic monocyte macrophage cell line RAW 264.7 was used as a model host cell for 
infection. At 1 hour post-infection, any remaining extracellular bacteria were killed by incubation with 
gentamicin. As this antibiotic cannot penetrate eukaryotic cells, this method ensures that only 
intracellular bacteria survive (Venkataraman et al., 1997). 
 The efficiency of L. pneumophila infection is highest at the transition between the exponential 
and stationary growth phases of the bacteria (Tiaden et al., 2013). Therefore, L. pneumophila broth 
cultures were diluted to an OD600 of 0.1 at 21 hours prior to infection to ensure that they reached the 
late exponential or early stationary growth phase at the time of infection, as described by Tiaden et 
al. (2003). Tissue culture plates were seeded with RAW 264.7 cells at 24 hours prior to infection, then 
adherent cells were infected with L. pneumophila cultures at the required MOI. The plates were then 
centrifuged for 5 minutes to bring the bacteria into contact with the cells and synchronise the infection 
(Harding et al., 2013). After incubation at 37°C for 1 hour, the infected cells were incubated with 
100μg/ml gentamicin for 1 hour in order to kill extracellular bacteria. The media was then removed 
from the plates, the wells were washed three times with PBS and incubated with antibiotic-free media 
at 37°C until the required time point was reached. This ensured that L. pneumophila could survive in 
the media and infect new host cells after release.  
 To ensure that the extracellular bacteria were sensitive to gentamicin, the minimum inhibitory 
concentration (MIC) was determined for L. pneumophila Paris and the representative L. pneumophila 
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isolates listed in Table 6. The results indicate that the MIC for all strains is 0.125μg/ml, as no bacterial 
growth was visible at this concentration and above (Figure 21). Therefore the gentamicin 
concentration of 100μg/ml used in the gentamicin protection assay far exceeded the MIC and was 
sufficient to kill any extracellular bacteria. 
Clade Representative isolate Accession number 
A 12_5415 NZ_CCZU00000000 
B 12_5064 NZ_CCZP01000000 
C 12_4499 NZ_CDCY00000000 
D 12_4240 NZ_CCZI00000000 
Table 6 Representative L. pneumophila isolates used in this study. 
 
 
Figure 21 Minimum inhibitory concentration of gentamicin on L. pneumophila Paris and representative isolates of clades A, 
B, C and D. Broth cultures of L. pneumophila were diluted to an OD600 of 0.02 in broth containing either 0, 0.0625, 0.125, 0.25, 
0.5 or 1μg/ml gentamicin. 200µl of each diluted sample was added to a 96-well tissue culture plate. The image was taken 
after incubation of the plate at 37°C for 1 week. 
  
 In order to achieve the required multiplicity of infection (MOI), the number of colony-forming 
units (CFUs) in the inoculum was determined by measuring the optical density at 600nm (OD600) of the 
bacteria in broth culture. A culture with an OD600 of 0.5 contains approximately 1x109 CFU/ml. This 
was confirmed by plating serial dilutions of the inoculum on CYE agar plates and counting the number 
of visible colonies after incubation at 37°C for up to 4 days.  
 RAW 264.7 cells were visualised using confocal microscopy after infection with L. pneumophila 
Paris at a range of MOIs, from 1 to 100 (Figure 22). Although a higher MOI resulted in the infection of 
a higher proportion of the cells, this also caused excessive host cell death, as determined by 




Figure 22 Representative confocal microscopy images of RAW 264.7 cells infected with L. pneumophila Paris at 2 hours post-
infection with MOI of 1, 10 or 100 (labelled). Cells were fixed on 13mm poly-L-lysine glass coverslips with PFA (4% 
paraformaldehyde in PBS; pH 7.4) for 20 minutes at room temperature. Cells were then permeabilised with 0.5% Triton X100 
for 15 minutes at room temperature. Non-specific binding sites were blocked with BSA/PBS for 30 minutes at room 
temperature. Legionella were stained with FITC-conjugated anti-Legionella antibody (green), F-actin was visualised with 
Phalloidin 568 (red) and DNA was stained with DAPI (blue). 
 
 An appropriate timescale for the infection was also determined using confocal microscopy. 
RAW 264.7 cells were visualised after infection with L. pneumophila Paris at 24, 48 and 72 hours 
post-infection (Figure 23). As intracellular bacteria were still visible at 72 hours post-infection, this 




Figure 23 Representative confocal microscopy images of RAW 264.7 cells infected with L. pneumophila Paris at an MOI of 1. 
Labels indicate hours post-infection. Cells were fixed on 13mm poly-L-lysine glass coverslips with PFA (4% paraformaldehyde 
in PBS; pH 7.4) for 20 minutes at room temperature. Cells were then permeabilised with 0.5% Triton X100 for 15 minutes at 
room temperature. Non-specific binding sites were blocked with BSA/PBS for 30 minutes at room temperature. Legionella 
were stained with FITC-conjugated anti-Legionella antibody (green), F-actin was visualised with Phalloidin 568 (red) and 
DNA was stained with DAPI (blue). 
 
 The first aim of the gentamicin protection assays was to measure the intracellular replication 
of the L. pneumophila isolates by quantifying colonies recovered from infected cells at several time 
points. At 24, 48 or 72 hours post-infection, the media was removed from the tissue culture plates 
and wells were washed twice with PBS to remove any extracellular bacteria. Next, 100µl 0.05% Triton 
X-100 (Sigma-Aldrich) in PBS was added to each well for 5 minutes in order to lyse the infected cells. 
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The resulting lysates were serially diluted in PBS, then 10µl of the tenfold dilutions were plated on 
BCYE agar plates before incubation at 37°C for 3 days or until colonies were visible. 
 Although viable colonies were recovered from infected cells at 24 hours post-infection (Figure 
24), none were recovered at later time points. This may have been due to the entry of the bacteria 
into a viable but non-culturable (VBNC) form in response to environmental stress (Oliver, 2010). In 
this form, the cells are viable but cannot be cultured on laboratory media. L. pneumophila may enter 
the VBNC state in response to starvation, hypochlorite treatment or high temperatures (reviewed in 
Al-Bana et al., 2014). Therefore, the number of colony-forming units recovered may not accurately 
reflect the number of intracellular bacteria due to the formation of VBNC cells.  
 
Figure 24 Colonies recovered on BCYE agar from lysis of RAW 264.7 cells infected with L. pneumophila Paris (MOI = 1) at 24 
hours post-infection. Plate shows 3 biological replicates. 10μl lysate (n) and tenfold serial dilutions in PBS (-1, -2, -3) from a 
total of 100μl lysate were plated from each well. 
 
 Several aspects of the protocol were modified in an attempt to recover viable colonies from 
later time points. For example, the infected cells were lysed with Triton X-100, so the effect of this 
detergent on cell viability was assessed. A broth culture of L. pneumophila Paris at approximately 106 
bacteria/ml was centrifuged in 1ml volumes at 13,000 x g for 1 minute. The resulting pellets were 
resuspended in 1ml of either 0%, 0.05% or 0.1% Triton X-100 in PBS. After incubation for 5 minutes at 
room temperature, each suspension was serially diluted in PBS, then 10μl of each tenfold dilution was 
plated on BCYE agar. The plates were incubated at 37°C until colonies were visible. 
 The results of this assay showed that 0.05% Triton X-100 does not inhibit the growth of 
colonies on BCYE agar (Figure 25). However, the bacteria used in this assay were taken from broth 




Figure 25 L. pneumophila colonies recovered on BCYE agar after incubation in PBS with 0%, 0.05% or 0.1% Triton X-100 for 5 
minutes prior to plating. 10μl (n) and tenfold serial dilutions in PBS (-1, -2, -3) of each suspension were plated. 
 
 Due to the time and cost of these experiments, alternative approaches were used to compare 
the replication of representative L. pneumophila isolates of clades A, B C and D. 
 
Growth curve of representative isolates in broth culture 
 One feature of the L. pneumophila isolates that could underlie the increased virulence of clade 
C and D isolates is their rate of replication. In order to compare the replication rate of each clade, a 
microplate reader was used to measure the OD600 of broth cultures of representative isolates. Each 
broth culture was diluted to a starting OD600 of 0.02 in either broth or DMEM, then 200µl of each 
diluted sample was added to a 96-well tissue culture plate. Growth was quantified hourly over 4 days 
by measuring OD600 using a microplate reader. No significant difference in replication rate was 
observed between representative isolates in broth culture, as determined by a student’s 2-sample t-
test (Figure 26 and Figure 27). In contrast, no replication was observed in DMEM (Figure 27). 
Therefore, any bacterial replication measured during gentamicin protection assays can be assumed to 




Figure 26 Doubling time of representative L. pneumophila isolates in broth culture as measured by change in OD600 at 
exponential phase. Error bars indicate the standard error of the mean across three biological replicates. 
 
 
Figure 27 Growth curve of representative L. pneumophila isolates in broth culture (solid lines) or DMEM (dotted lines) as 
measured by OD600 at 1 hour intervals using a microplate reader set at 37°C and shaking. Lines represent mean result from 
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Intracellular growth of representative L. pneumophila isolates 
 During infection, bacteria must replicate efficiently inside their host in order to spread to other 
cells (Finlay and Falkow, 1997). A higher rate of intracellular replication increases the number of 
bacterial cells available to infect new host cells, and may therefore increase the virulence of the 
bacteria. Therefore, representative isolates from each clade were compared to identify any 
differences in replication rate that could underlie the increased virulence of clade C and D isolates in 
the Galleria model. 
 Confocal microscopy was used to visualise any gross differences in the infection of RAW 264.7 
cells with representative L. pneumophila isolates of each clade, listed in Table 6. At 30 minutes post-
infection (MOI = 1), bacteria from each clade were visible inside RAW 264.7 cells, indicating no obvious 




Figure 28  Confocal microscopy images of RAW 264.7 cells infected with representative L. pneumophila isolates of each clade 
(labelled) at 30 minutes post-infection. RAW 264.7 cells seeded on 13mm poly-L-lysine glass coverslips were inoculated at an 
MOI of 1. After centrifugation at 500rpm for 5 minutes, the infected cells were incubated in antibiotic-free media at 37°C for 
30 minutes. Media was then removed from the plate and each well was washed twice with PBS. Cells on the coverslips were 
fixed with PFA (4% paraformaldehyde in PBS; pH 7.4) for 20 minutes at room temperature. Cells were then permeabilised 
with 0.5% Triton X100 for 15 minutes at room temperature. Non-specific binding sites were blocked with BSA/PBS for 30 
minutes at room temperature. Legionella were stained with FITC-conjugated anti-Legionella antibody (green), F-actin was 
visualised with Phalloidin 568 (red) and DNA was stained with DAPI (blue). 
 
 Real-time quantitative PCR (qPCR) was used to quantify the number of Legionella inside 
infected RAW 264.7 cells over time. In this assay, multiple PCRs are monitored simultaneously in the 
thermal cycler, which detects the change in the fluorescent signal that is emitted by the dye SYBR 
Green I when it binds double-stranded DNA (Higuchi et al., 1993). The number of cycles at which the 
fluorescence level becomes statistically significantly higher than the background level is known as the 
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threshold cycle (Ct). As the Ct is inversely proportional to the log of the initial copy number, it can be 
used to compare the number of copies of a gene of interest in multiple DNA samples (Dieffenbach and 
Dveksler, 1995). 
 For each reaction, an amplification plot is generated with tenfold serial dilutions of the 
amplification product. The Ct of each dilution is then plotted against the initial DNA quantity of each 
dilution, and the resulting gradient is used to calculate PCR efficiency (E) of one cycle during the 
exponential phase according the equation: E = 10-1/gradient (Rasmussen, 2001). The relative expression 
ratio (R) of a target gene is calculated using the Ct of an unknown sample versus a control, according 
to the equation: R = E ΔCt(control – unknown) (Pfaffl, 2001). 
 DNA samples were prepared by infecting RAW 264.7 cells with representative isolates of each 
clade at an MOI of 1. The DNA samples were extracted at 30 minutes, 2 hours, 4 hours and 24 hours 
post-infection using the QIAamp® DNA Mini Kit (Qiagen). Primers were designed to probe the DNA 
samples for the Legionella gene icmQ and the RAW 264.7 cell gene β-actin. The primers were validated 
by PCR on genomic DNA extracted from RAW 264.7 cells infected with the representative Legionella 
isolate from clade A (Figure 29).  
 
Figure 29 PCR validation of primers for the genes icmQ and β-actin on genomic DNA extracted from RAW 264.7 cells infected 
with Legionella clade A isolate 12_5415 (MOI=1) at 2 hours post-infection. Negative controls (-) contain no DNA. 
 
 Appropriate primer concentrations for qPCR were determined by amplification plots of the 
two genes with a range of primer concentrations (Figure 30). These plots showed that primer 
concentrations of 300nM and 200nM were sufficient for reactions with the primers for icmQ and β-
actin, respectively. Dissociation curves were also generated for each pair of primers to determine the 
melting temperature of the amplification products (Figure 31). The single sharp peak present in each 
plot indicates the presence of a single amplification product and therefore high specificity of the 
primers and no primer dimer formation. Across three biological and technical replicates, the mean 
efficiency of the primers for icmQ and β-actin were 2.39 and 2.13, respectively (correlation coefficient 




Figure 30 Amplification plots with primers for icmQ and β-actin at 100nM, 200nM or 300nM. The genomic DNA sample 





Figure 31 Dissociation curve with forward and reverse primers for icmQ and β-actin at 100nM, 200nM or 300nM. The 
genomic DNA sample used was extracted from RAW 264.7 cells infected with Legionella clade A isolate 12_5415 (MOI=1) at 
2 hours post-infection.  
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 This qPCR assay was used to compare the relative number of Legionella inside RAW 264.7 cells 
at 30 minutes after infection with representative isolates of each clade. In this assay, the relative 
quantity of icmQ and β-actin was compared between 10µg DNA samples from cells infected with each 
isolate. For each gene, the relative expression ratio was calculated relative to sample with the highest 
Ct (and therefore lowest initial copy number) of the four samples. The ratio of Legionella to RAW 264.7 
cells was then calculated by dividing the relative expression ratio of icmQ by that of β-actin (Figure 
32). 
 
Figure 32 Relative number of intracellular Legionella at 30 minutes post-infection as determined by real-time qPCR. Error bars 
show standard error across three biological and technical replicates. 
 
 The results show a significant difference in the number of intracellular Legionella in RAW 264.7 
cells infected with clade B and C isolates, as determined by a student’s 2-sample t-test (Figure 32). As 
the infections were all carried out at an MOI of 1, verified by plating serial dilutions of the inoculum, 
this variation could be due to a difference in the efficiency of host cell invasion between the isolates. 
Therefore, when quantifying the intracellular replication of each isolate by qPCR, the relative 
expression ratios were calculated relative to the Ct at 30 minutes post-infection. The ratio of 
Legionella to RAW 264.7 cells was then calculated by dividing the relative expression ratio of icmQ by 
that of β-actin (Figure 33).  
 The results of the real-time qPCR experiment indicate that isolates from clades A and B 
showed higher net replication than those from clades C and D (Figure 33). The fold change was 
significantly higher in the clade A isolate than the clade D isolate. These results suggest an inverse 
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correlation between net intracellular replication and virulence in the Galleria infection model 
described by McAdam et al. (2014). 
 
Figure 33 Fold change in the number of intracellular Legionella as determined by real-time qPCR. Bar labels indicate the 
clade of each representative isolate. Error bars show standard error across three biological and technical replicates. 
  
 Another example of this inverse correlation is found in the Salmonella enterica serovar 
Choleraesuis, which causes systemic disease with a high mortality rate in pigs (Paulin et al., 2007). In 
contrast, the serovar Typhimurium causes acute enteritis but is rarely fatal. Typhimurium shows 
greater net replication than Choleraesuis in the intestinal mucosa, where it causes a greater induction 
of proinflammatory cytokines. It is thought that the rapid pro-inflammatory response triggered by 
Typhimurium may confine the infection to the intestine, whereas the slower replication of 
Choleraesuis may facilitate evasion from the host immune response and the resulting systemic 
disease. Furthermore, it has been suggested that the slow growth rate of Mycobacterium tuberculosis 
may prevent rapid death of the host and thereby promote dissemination of the bacteria (Ernst et al., 
2007). 
 
Cell cytotoxicity assay 
 A cytotoxicity assay was used to compare the rate of host cell death during infection with 
representative isolates of each clade (Figure 34). The CytoTox 96® Non-Radioactive Cytotoxicity Assay 
(Promega) was used to measure the amount of lactate dehydrogenase (LDH) released by infected 
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RAW 264.7 cells into the supernatant at 2, 4 and 24 hours post-infection during a gentamicin 
protection assay (MOI =1). LDH release is used as a measure of cytotoxicity as this cytosolic enzyme is 
released from dead or damaged cells (Parhamifar et al., 2013). In this assay, LDH catalyses the 
conversion of NAD+ into NADH, which results in the conversion of a yellow tetrazolium salt into red 
formazan. This colour change is proportional to the amount of LDH and therefore the number of lysed 
cells, and can be measured by the absorbance of the supernatant at 490nm.  
 
Figure 34 Cell cytotoxicity assay. Bar labels indicate uninfected cells (-) or the clade of the representative isolate used for 
infection. Error bars show standard error across three biological replicates. 
 
 In this assay, the absorbance at 490nm was measured using the FLUOstar Optima microplate 
reader (BMG LabTech). The percentage of lysed cells was calibrated using phenol red-free DMEM as 
the negative control (0%) and uninfected cells incubated with Lysis Solution (Promega) for 45 minutes 
as the positive control (100%). The assay was optimised by using phenol red-free DMEM during the 
infections to ensure that the colour change of the assay was not affected by the presence of phenol 
red in the supernatant. In addition, the supernatant samples were centrifuged at 300 x g for 4 minutes 
to remove any detached cells that may have been present. This step ensured that the supernatant 
samples did not contain any additional LDH released from the detached cells when the samples were 
frozen for storage before the assay was performed. 
 The results of the cytotoxicity assay show no significant difference in the rate of cell death 
during infection with isolates of each clade, as determined by a student’s 2-sample t-test (Figure 34). 
Furthermore, no significant difference was observed between the rate of cell death in uninfected and 
infected cells. This evidence indicates that the isolates do not activate pyroptosis. This could be 


































verified by quantifying IL-1β and IL-18 released from the host cell as a measure of caspase-1 activation 
and pyroptosis (Case and Roy, 2013). 
 
LC3 conversion assay 
 In order to survive inside the host cell, L. pneumophila escapes the autophagy pathway and 
thereby evades lysosomal degradation of the LCV (reviewed in Xu and Luo, 2013). Autophagy clears 
intracellular pathogens by packaging them into phagosomes, which then fuse with lysosomes to 
degrade the enclosed pathogens (Xie and Klionsky, 2007). The autophagy pathway of infected cells is 
inhibited by the L. pneumophila effector protein RavZ (Choy et al., 2012). Although the gene encoding 
RavZ is present in all 4 of the clades, it is possible that one or more of the predicted novel effectors 
could also be involved in modulating host cell autophagy. 
 Therefore, the level of LC3 conversion was determined as a measure of autophagy in RAW 
264.7 cells during infection with representative isolates of each clade. In mammalian cells, the 
microtubule-associated protein 1 light chain 3 (LC3) is found in two distinct forms, LC3-I and LC3-II 
(Kabeya et al., 2000). LC3-I is present in the cytosol, whereas LC3-II is a lipidated form which specifically 
binds to autophagosome membranes (Tanida et al., 2004). The conversion of LC3-I to LC3-II correlates 
with autophagosome formation and is therefore used as a marker of autophagy. 
 RAW 264.7 cells were inoculated with either representative L. pneumophila isolates (MOI = 1) 
or DMEM (uninfected control), then lysed with BugBuster™ Protein Extraction Reagent (Novagen) at 
2, 4 or 24 hours post-infection. The resulting lysate samples were separated by SDS-PAGE, then 
visualised by western blotting with an antibody against LC3 (Figure 35). The intensities of LC3-I and 
LC3-II in each sample were quantified using the Li-Cor Odyssey infrared imager and Li-Cor Image Studio 
software. The ratio of LC3-II to total LC3 was then calculated as a measure of autophagy (Figure 36). 
  No significant difference was observed between cells infected with representative isolates, 
or between infected and uninfected cells, as determined by a student’s 2-sample t-test. However, 
significant inhibition by the clade D isolate at 24 hours post-infection may be seen with further 




Figure 35 LC3 conversion assay by western blot. Data from 2 biological replicates is shown. Each lane contains a lysate sample 
from either uninfected cells (-) or cells infected with a representative isolate (A, B, C, D) at 2, 4 or 24 hours post-infection (hpi). 
Actin was used as a loading control. 
 
 
Figure 36 LC3 conversion assay. Bar labels indicate uninfected cells (-) or the clade of the representative isolate used for 
infection. Error bars show standard error across two biological replicates. 
 
 




































 The replication rates of L. pneumophila isolates from each clade were compared in both broth 
culture and infected RAW 264.7 cells. No significant difference in replication was observed in broth 
culture. In contrast, the net intracellular replication of clades A and B was higher than that of clades C 
and D, suggesting an inverse correlation between intracellular replication rate and virulence. 
However, assays for cell cytotoxicity and autophagy showed no significant difference between cells 




Chapter 5: General discussion 
Identification of a novel T4SS-encoding pathogenicity island 
 Bioinformatic analysis has shown that the unique 39-kb region identified in clades C and D 
closely resembles a pathogenicity island. These islands carry one or more virulence genes, and 
therefore contribute to rapid changes in the virulence of a species (Dobrindt et al., 2004). Virulence 
genes previously found on other pathogenicity islands encode proteins with a range of different 
functions including adherence, iron uptake, capsule formation, entry into host cells and secretion 
systems. It is therefore possible that the 39-kb region also carries virulence genes, which could 
underlie the increased virulence of clade C and D isolates. 
 A 65-kb pathogenicity island found in 41 L. pneumophila strains has also been identified in 
three strains of Legionella anisa, indicating that the islands may be transferred between different 
Legionella species (Cazalet et al., 2008). This finding supports the hypothesis that the 39-kb region 
was transferred to some of the Edinburgh outbreak L. pneumophila strains from L. longbeachae in the 
environment. 
 The Legionella genomic island (LGI-2) identified in L. pneumophila Corby can be transferred 
by conjugation (Lautner et al., 2013). LGI-2 is excised from the chromosome, generating a circular 
episomal form of the island, which can be transferred to another L. pneumophila strain. Lautner et al. 
(2013) used primers specific to either the circular or chromosomal form of the genomic island in order 
to determine the rate of excision by real-time qPCR. This technique could be used to determine 
whether or not the 39-kb region is excised and therefore a functional genomic island.  
  
Acquisition of the pathogenicity island from L. longbeachae 
 The 39-kb region was found to share 94% nucleotide identity with the homologous region in 
a L. longbeachae isolate from a compost sample provided by a Legionnaires’ disease patient. This 
patient was one of six people infected with L. longbeachae in Scotland between August and September 
2013 (Potts et al., 2013). All six of these patients required intensive care and notably, all were amateur 
gardeners who had been exposed to horticultural growing media during their incubation period. This 
finding has significance as commercial compost is thought to be the main source of human infection 
by this species (Health Protection Scotland, 2013). 
 L. longbeachae was detected in five samples of growing media linked to five of the patients. 
The same amplified fragment length polymorphism (AFLP) DNA profile was found in isolates from the 
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patients and isolates from the growing media that they had been working with (Health Protection 
Scotland, 2014). However, whole genome sequencing showed that there was no close relationship 
between isolates from the patients and the growing media linked to each case. 
 L. longbeachae causes around 50% of cases of Legionnaires’ disease in Australia (NNDSS 
Annual Report Writing Group, 2015). Unfortunately, L. longbeachae infections test negative using 
routine Legionella urinary antigen tests, as these only detect L. pneumophila (Health Protection 
Scotland, 2013). Therefore L. longbeachae can only be identified by elevated antibody titre, PCR and 
culture. 
 The interaction between L. longbeachae and its host cells is thought to be distinct from that 
of L. pneumophila, as the L. longbeachae genome encodes a unique set of putative Dot/Icm T4BSS 
effectors and eukaryotic-like proteins (Cazalet et al., 2010). Unlike L. pneumophila, L. longbeachae 
does not trigger caspase-1 activation in murine macrophages, and is therefore able to replicate inside 
the lungs of C57BL/6 and BALB/c mice (Asare et al., 2007). Therefore, the acquisition of L. longbeachae 
genes could provide L. pneumophila with novel virulence determinants or survival mechanisms. 
   
Predicted T4SS-secreted effector proteins 
 mRNA encoding the predicted effector protein 00662 was detected during the infection of 
RAW 264.7 cells with L. pneumophila isolates of clades C and D. However, expression of predicted 
effector mRNA was only studied at 18 hours post-infection, so it is possible that the other predicted 
effectors are expressed at either earlier or later stages of infection and were missed in this analysis. 
RNA samples could be taken at hourly time points to determine the time at which expression is 
induced.  
 Expression of the predicted effector protein 00662 could be validated by the construction of 
a fusion protein with a c-Myc tag, which could then be detected using an antibody against the c-Myc 
epitope. Secretion of this fusion protein by the newly identified LGI-T4SS could be verified by 
transfecting the plasmid encoding the fusion protein into isolates with and without the 39-kb region. 
Secretion of the protein during broth culture could then be determined by western blot analysis of 
the supernatant. Secretion and localisation of the protein during host cell infection could also be 
studied by immunohistochemistry. 
 Figure 37 shows the predicted eukaryotic-like linear motifs in the protein encoded by 00662. 
The predicted functions of these motifs (discussed below) could be verified by assays such as an in 
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vitro actin polymerisation assay for the WH2 actin-binding motif. In addition, deletion mutants could 
be constructed to determine the requirement of each domain in intracellular replication or virulence. 
To determine the requirement of the LGI-T4SS, 00662 or other predicted effectors in the virulence of 
Legionella, knockout mutants could be constructed and compared with wild-type strains in infection 
models. 
 
Figure 37 Location and probability of predicted eukaryotic linear motifs in protein 00662 as determined by the eukaryotic 
linear motif resource ELM (http://elm.eu.org) (Dinkel et al., 2013). 
 
Fbw7-binding motif 
 Fbw7 (F-box and WD repeat domain-containing protein 7) is an F-box protein that acts as a 
substrate receptor for a class of E3 ubiquitin ligases called SCF (Skp1 Cullin-1 F-box) ligases (Davis et 
al., 2014). E3 ubiquitin ligases facilitate the covalent attachment of ubiquitin to a specific protein 
(Schwartz and Ciechanover, 2009). This marks the protein for degradation by the 26S proteasome as 
part of the ubiquitin-proteasome system (UPS). The UPS is a major pathway for the degradation of 
regulatory proteins in the eukaryotic cell (Crusio et al., 2010). Therefore, the UPS has far-reaching 
effects including the regulation of cell division, apoptosis and inflammation (Finley, 2009).  
 In an SCF E3 ubiquitin ligase, Skp1 links the complex to an interchangeable F-box protein via 
its F-box domain, thereby conferring substrate specificity (Welcker and Clurman, 2008) (Figure 38). 
The SCF-Fbw7 complex (SCFFbw7) is thought to target over twenty cellular proteins with roles in 
proliferation, apoptosis and metabolism (Davis et al., 2014). The majority of Fbw7 substrates are 




Figure 38 SCF ubiquitin ligase complex (Welcker and Clurman, 2008). Cullin-1 (CUL1) links the RING protein RBX1 to SKP1 
(Zheng et al., 2002). The RING subunit recruits an E2 ubiquitin-conjugating enzyme (UBC) and Skp1 binds an F-box protein, 
which binds the substrate (Petroski and Deshaies, 2005, Bai et al., 1996). The E1 ubiquitin-activating enzyme (UBA) transfers 
a ubiquitin molecule to the E2 ubiquitin-conjugating enzyme (UBC) (Alberts et al., 2008b). Next, the UBC forms a complex 
with the SCF E3 ubititin ligase, which binds the protein substrate. The UBC then assembles a polyubiquitin chain on the 
substrate protein. 
 
 For example, one of the Fbw7 substrates is a transcription factor and proto-oncogene called 
c-Myc (Yada et al., 2004). This protein is expressed transiently as cells enter the G1 phase of the cell 
cycle and promotes cell proliferation. Depletion of Fbw7 by RNA interference has been shown to 
increase the abundance and activity of c-Myc. SCFFbw7 also targets other proto-oncogenes such as 
cyclin E, Notch and Jun (Welcker and Clurman, 2008). Therefore, it can be considered to be a tumour 
suppressor. Notably, the Fbw7 gene is one of the most frequently mutated genes in human cancers 
(Davis et al., 2014). 
 The binding of Fbw7 by 00662 may inhibit its substrate receptor activity, thereby preventing 
the ubiquitination and degradation of host cell proteins by the UPS. The resulting accumulation of host 
cell proteins may increase proliferation or reduce apoptosis of the host cell, thereby protecting the 
replicative niche of L. pneumophila and facilitating intracellular replication. 
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WH2 motif  
 The WH2 domain (WASP homology domain 2) binds actin monomers and is present in many 
regulators of the actin cytoskeleton (Paunola et al., 2002). Several species of bacteria secrete effector 
proteins containing WH2 domains via a Type III Secretion System (Yu et al., 2011). For example, the 
Vibrio cholerae effector VopF disrupts the actin cytoskeleton of eukaryotic host cells via its WH2 
domain (Tam et al., 2007). 
 The actin cytoskeleton of the eukaryotic host cell is involved in many vital processes, including 
endocytosis, phagocytosis and cell division (Alto and Orth, 2012). Therefore, an actin-binding WH2 
domain in 00662 could promote intracellular L. pneumophila survival via several different 
mechanisms. For example, disruption of the actin cytoskeleton may inhibit vesicle trafficking and 
thereby protect the LCV from lysosomal degradation. Alternatively, reorganisation of the actin 




 Inhibitor of apoptosis proteins (IAPs) suppress apoptotic cell death (Salvesen and Duckett, 
2002). IAPs contain baculoviral IAP repeat (BIR) domains, which bind to and inhibit active caspases 
(Prunell and Troy, 2004) (Figure 39). IAP antagonists act by displacing bound caspases from the BIR 
domains of IAPs (Orme and Meier, 2009).  
 
Figure 39 The human IAP family contains BIR (baculoviral IAP repeat), NACHT (NAIP, C2TA, HET-E and TP1), UBC (ubiquitin 
conjugation) and LRR (leucine-rich repeat) domains (Eckelman et al., 2006). 
 
 The predicted IAP-binding motif on 00662 binds specifically to Type II BIR domains, which are 
found in two mammalian proteins, Survivin and Bruce/Apollon (Lens et al., 2006). Survivin plays an 
essential role in chromosome segregation and cytokinesis during cell division. In contrast, 
Bruce/Apollon is an IAP that prevents SMAC-induced apoptosis by facilitating the proteasomal 
66 
 
degradation of caspase-9 and the pro-apoptotic molecule SMAC via IAP-binding motifs (Hao et al., 
2004). 
 A type II BIR domain is present on the Naip5 protein, which is required for flagellin-induced 
caspase-1 activation in resistant macrophages (Eckelman et al., 2006, Amer et al., 2006). Therefore, 
inhibition of Naip5 by 00662 could prevent caspase-1 activation. This would inhibit fusion of the LCV 
with the lysosome, prevent host cell pyroptosis and promote survival of L. pneumophila inside the 
host cell. 
 
Clathrin box motif  
 Clathrin-coated vesicles transport material between the plasma membrane, endosomes and 
Golgi compartments (Alberts et al., 2008a). Clathrin protein subunits are comprised of three heavy 
and three light polypeptide chains, forming a triskelion structure. These assemble into a framework 
on the cytosolic surface of membranes. Adaptor proteins form a layer between the clathrin framework 
and the membrane, where they bind the clathrin to the membrane via lateral interactions.  
 The clathrin box motif on 00662 is found on adaptor proteins, and interacts with the clathrin 
heavy chain. This interaction may therefore inhibit the formation of clathrin-coated vesicles in the 
host cell and disrupt intracellular trafficking. 
 
Measuring intracellular replication of L. pneumophila 
 During intracellular growth, L. pneumophila can differentiate into several different phenotypic 
forms (Garduno et al., 2002). This introduces several limitations into the quantification of intracellular 
Legionella replication. For example,  quantifying L. pneumophila colonies plated on CYE agar plates is 
skewed in favour of bacteria that are present in a particular phenotypic form that supports growth on 
agar (Tiaden et al., 2013). The efficiency of DNA extraction is also affected by the presence of different 
phenotypic forms. For example, the mature intracellular form (MIF) is resistant to detergent-mediated 
lysis, thereby reducing the efficiency of DNA extraction (Garduno et al., 2002). Therefore, DNA 
extraction also skews qPCR quantification of L. pneumophila in favour of those present in a particular 
phenotypic form. 
 Nevertheless, relative numbers of intracellular bacteria were measured by real-time qPCR. 
However, the growth curves recorded in broth culture show that L. pneumophila replication can take 
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several days. Therefore, it would be useful to extend the qPCR experiment to compare replication 
rates at later time points. In addition, it would be useful to validate the results in human cell lines, 
such as U937 macrophages, THP-1 monocytes or HL-60 promyelocytic cells. 
 An alternative method for quantifying intracellular replication is flow cytometry (Tiaden et al., 
2013). Bacteria that constitutively express green fluorescent protein (GFP) can be quantified by GFP 
fluorescence intensity, thereby providing a method for real-time analysis of intracellular replication 
that is sensitive, fast and accurate.  
 
Measuring host cell responses and virulence 
 The LC3 conversion assay showed no significant difference in inhibition of autophagy between 
isolates of the four clades. However, this assay could be optimised by carrying out the infection of 
RAW 264.7 cells under starvation conditions using FCS-free media (Kabeya et al., 2000). This would 
induce autophagy in the host cells and therefore provide more conclusive evidence of any inhibition 
by the Legionella isolates. 
 To determine the mechanism underlying the difference in virulence between the clades, other 
aspects of the host cell response could be studied. For example, pore formation during host cell 
pyroptosis could be measured by incubation with propidium iodide (Case and Roy, 2013). This 
molecule can pass through pores in the cell membrane and bind to nucleic acid. The fluorescence of 
propidium iodide increases when bound to nucleic acid, and can therefore be used as a measure of 
pore formation in real time using a multi-well fluorescence plate reader. Alternatively, the level of IL-
1β and IL-18 released by the host cell can be quantified by ELISA as a measure of pyroptosis. 
 McAdam et al. (2014) used a Galleria mellonella infection model to compare the virulence of 
L. pneumophila isolates from each clade. Although this has been shown to be an effective model for 
human infection, an in vivo mammalian infection model could be used to validate these results 
(Harding et al., 2012). For example, two well-studied models are the guinea pig and the A/J mouse 







 The results of this report indicate that the novel T4SS identified in the L. pneumophila 
outbreak isolates is an LGI-T4SS that originated in L. longbeachae. The novel region also encodes at 
least one putative T4SS-secreted effector protein, which contains several eukaryotic-like motifs. These 
motifs could facilitate host cell interactions and thereby underlie the increased virulence of isolates 
containing the novel region. In addition, an inverse correlation was shown between the presence of 
the novel region and net intracellular replication. Future work could build on these findings to 
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